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Ethanol exposure during synaptogenesis can result in brain and behavior 
neurotoxic defects referred to as fetal alcohol syndrome (FAS).  Since tissue 
plasminogen activator (tPA) has been implicated in mediating excitotoxic 
neurodegeneration we subjected neonatal WT and tPA-/- to an acute ethanol 
paradigm that serves as a model of FAS.  We observed persistent 
upregulation of tPA and extensive neurodegeneration after ethanol in the 
forebrain of WT. However, tPA-/- mice were protected from neuronal death, 
suggesting tPA mediates ethanol-induced neurodegeneration and FAS in 
mice.  Commensurate with neuronal death, we observed ethanol-induced 
cognitive impairments in adult WT, but not tPA-/- mice.  To understand how 
ethanol affects tPA we subjected mice to drugs that mimic the actions of 
ethanol in the brain. tPA-/- mice were protected from neurodegeneration after 
treatment with NMDA-R antagonist, but not after GABAA-agonist, 
suggesting tPA acts via an NMDA-R mediated mechanism.  We also 
investigated the role of the tPA inhibitor plasminogen activator inhibitor-1 
(PAI-1) in FAS.  We observed PAI-1-/- mice were more vulnerable to 
ethanol-induced neurodegeneration than WT mice.  In addition, we found 
that tPA-/-:PAI-1+/- mice treated with ethanol showed increased 
neurodegeneration than tPA-/- mice.  These results suggest PAI-1 is involved 
in neuronal survival after ethanol.  Finally, we explored the role of tPA in 
hippocampal synaptic plasticity after chronic stress.  We restrained WT, 
tPA-/-, and PAI-1-/- mice for 21 days.  We found chronic stress increased tPA 
activity in WT and PAI-1-/- mice. Stress greatly reduced PAI-1 below 
baseline levels in WT mice.  These stress-induced changes in tPA activity 
and PAI-1 resulted in decreased contextual fear conditioning in WT and 
PAI-1-/- mice.  Chronic stress did not affect contextual learning in the tPA-/- 
mice.  These results suggest tPA is necessary for the synaptic plasticity 
cascade that causes cognitive deficits after chronic stress exposure. 
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CHAPTER 1: INTRODUCTION 
 
 
1.1 Fetal alcohol syndrome 
 
      Ethanol exposure during synaptogenesis can result in neurotoxic brain 
defects referred to as fetal alcohol syndrome (FAS). The syndrome can lead 
to myriad of mental health problems including cognitive deficits, mental 
retardation, psychosis, depression, hyperactivity, and schizophrenia (Jones 
and Smith, 1973; Swayze et al, 1977; Kerns et al, 1977; Clarren and Smith, 
1978; Sulik et al, 1981; Famy et al, 1998). According to the Center for 
Disease Control and Prevention, FAS is the leading preventable cause of 
mental retardation in the U.S. with a rate of 1 case developing the disorder 
for every 500 live births. There is no cure for FAS, yet the syndrome afflicts 
more babies born every year in the United States than the combined total of 
infants born with Down’s syndrome, muscular dystrophy, and HIV 
combined.  
     Following the ethanol exposure that leads to FAS, there is significant 
brain mass loss and widespread neuronal death. The developing brain is 
more vulnerable to ethanol-induced neurodegeneration during 
synaptogenesis (West, 1987; Dobbing and Sands, 1979; Goodlet and West, 
1992), an activity-dependent process.  Rats exposed to ethanol during the 
synaptogenesis period at postnatal day 7 are vulnerable to ethanol-induced 
 1
neuronal death, while animals exposed to the same dose at postnatal day 21, 
when synaptogenesis has ended, are resistant to neurodegeneration (Heaton 
et al, 2003).   
     Ethanol reduces neuronal activity through a dual mechanism: antagonism 
of the N-Methyl-D-Aspartate receptor (NMDA-R) and potentiation of the 
gamma amino butyric acid type A receptor (GABAA-R) (Hoffman et al, 
1989; Lovinger et al, 1989; Harris et al, 1995; Ikonomidou et al, 1999 and 
2000).  Drugs that mimic ethanol via inhibition of NMDA-R or 
hyperactivation of GABAA-R lead to a pattern of neurodegeneration that 
when composited together resemble what is observed after exposure to 
ethanol in neonatal rats (Ikonomidou et al, 1999 and 2000).  
     During synaptogenesis multiple subsets of CNS neurons depend on 
depolarization-induced elevation of intracellular calcium and the subsequent 
activation of multiple signaling cascades to survive.  NMDA-R blockade by 
ethanol can inhibit these survival signals (Mennerick and Zorumski, 2000). 
A single large dose of ethanol administered during synaptogenesis leads to 
widespread neurodegeneration, and subsequent behavioral impairments in 
cognitive tasks in rodents that mimic those seen in humans with FAS 
(Ikonomidou et al, 2000; Dikranian et al, 2001, Maas et al, 2005; Olney et 
al, 2002; Ieraci and Herrera, 2006).  
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Furthermore, mice deficient in adenylyl cyclases 1 and 8, which are crucial 
components of the cAMP signal transduction pathway and are directly 
stimulated by calcium, are more vulnerable to ethanol-induced 
neurodegeneration (Maas et al, 2005).      
     Neuronal death is dependent on the activation of the key apoptotic 
protease caspase-3 (Olney et al, 2002), and entails the release of cytochrome 
c from the mitochondrial membrane (Young et al, 2003).  Treatment with 
nicotinamide following ethanol exposure can diminish activation of the 
apoptotic cascade, reduce neurodegeneration, and consequently prevent 
ethanol-induced behavioral impairments such as hyper-activity and 
decreased contextual fear conditioning in mice (Ieraci and Herrera, 2006).  
Neurodegeneration is observed most prominently in the cerebral cortex, 
thalamus, hippocampus, and cerebellum in rodents (Ikonomidou et al, 2000; 
Dikranian et al, 2005). The improper development of neural circuits due to 
ethanol-induced mass deletion of neuronal populations in these brain regions 
is thought to underlie the deficits in learning, memory, and locomotion 
observed in adult animals in a model of FAS.  Furthermore, identification of 
the mechanisms by which ethanol induces neurodegeneration in the 
developing brain is relevant to other clinical scenarios, including pediatric 
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anesthesia, antiepileptic therapy, and exposure of the immature brain to 
other NMDA-R antagonist drugs or GABAA-R agonists. 
  
1.2 Tissue-type plasminogen activator in CNS physiology 
     Tissue plasminogen activator (tPA) is a highly specific serine protease 
expressed in the vasculature where it initiates fibrinolysis via activation of 
the inactive zymogen plasminogen into plasmin (Carmeliet et al, 1994; 
Collen D, 1999).  tPA is also expressed in the central nervous system (CNS), 
in neurons and microglia, where it plays multiple extravascular roles, both 
plasminogen dependent and independent (for a reviews see Melchor and 
Strickland, 2005; Benchenane et al, 2004). In neurons, tPA is stored in 
dense-core vesicles, transported to axon terminals, and released into the 
extracellular space in a regulated manner (Gualandris et al, 1996).  tPA 
activity in the CNS is specifically regulated by the serine protease inhibitors 
(serpins) plasminogen activator inhibitor-1 (PAI-1) and neuroserpin. 
      The tPA/plasmin system is involved in neuronal growth cone penetration 
(Krystosek and Seeds, 1981), and migration of cerebellar granule neurons 
during development (Friedman and Seeds, 1995).  tPA is also critical in 
synaptic plasticity processes that are necessary for learning and memory and 
long-term potentiation (LTP) (Qian et al, 1993; Seeds et al 1995; Baranes et 
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al, 1998; Pawlak et al, 2003; Norris and Strickland, 2007), and there is 
evidence that strongly suggests tPA regulates these functions via direct 
modulation of the NMDA-R (Norris and Strickland, 2007).  In addition to 
normal CNS physiology, inappropriate tPA activity also plays a role in CNS 
pathology.  tPA mediates excitotoxic neuronal death in the hippocampus 
after kainic acid (KA) treatment, and tPA-deficient mice are protected from 
KA-induced neurodegeneration (Tsirka et al, 1995; Chen et al, 1997; Indyk 
et al, 2003).  Furthermore, chronic ethanol increases tPA activity in the 
hippocampus of adult mice. tPA interacts with the NR2B subunit of the 
NMDA-R, and ethanol-induced increase of tPA is required for increase in 
NR2B in the hippocampus, consequently resulting in ethanol withdrawal 
seizures (EW) in adult animals and neurodegeneration (Pawlak et al, 2005; 
Skrzypiec et al, 2008-submitted). Since tPA mediates ethanol-induced 
modulation of the NMDA-R, which is a main target for ethanol in the CNS, 
it became clear tPA was an appropriate candidate to investigate in the 
development of FAS. 
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1.3 NMDA-R  
 
     Excitatory glutamatergic signaling mediated by the NMDA-R, a subtype 
of glutamate ionotropic receptor, is critical during developmental 
synaptogenesis. The heightened level of NMDA receptor activity during 
development allows for increased influx of calcium, which acts as a 
secondary signal, eventually leading to the translation of proteins required 
for neuronal differentiation through activation of immediate early genes 
(IEG) (Ghiani et al, 2007).  
     The NMDA-R complex consists of obligatory NR1 subunits that bind the 
co-agonist glycine, assembled with NR2 subunits (NR2A, NR2B, NR2C) 
that bind glutamate. A functional NMDA-R consists of two NR1, and at 
least one type of NR2 (NR2A-D) (Cull-Candy et al, 2001).  The composition 
of NR2 is usually homomeric (i.e. NR2A/NR2A or NR2B/NR2B) and very 
rarely heteromeric (e.g. NR2A/NR2B).  Each subunit consists of 4 
transmembrane domains and an intracellular carboxyl terminal-domain 
(CTD) and an extracellular amino-terminal domain (ATD).   
     The NMDA-R is a central target in the CNS for the neurobehavioral 
effects of ethanol (Hoffman et al, 1989; Lovinger et al, 1989). Ion flux 
through the NMDA-R is inhibited by ethanol, with the NR2A- and NR2B-
containing receptors showing higher sensitivity to ethanol inhibition than 
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NR2C- and NR2D-containing receptors (Masood et al, 1994; Mirshani and 
Woodward, 1995).  Furthermore, chronic ethanol exposure of adult animals 
results in increased NMDA-R number, as determined by ligand binding 
studies, and increased expression of NR1, NR2B, and NR2A (Grant et al, 
1990; Follesa and Ticku, 1995; Snell et al, 1996). 
      The NR2 subunit composition confers different biophysical and 
pharmacological properties on the receptor.  NR2B-containing receptors 
have greater and longer acting excitatory post-synaptic currents (EPSCs) 
than NR2A-containing NMDA-R (Cull-Candy et al, 2001; Sheng and Kim, 
2002).  In the mature brain, NR2B-containing receptors are mostly found at 
extrasynaptic sites requiring higher concentrations of glutamate (spill-over) 
than synaptic receptors to be stimulated, which has been speculated to 
underlie the developmental changes observed in excitotoxicity (Zhou and 
Baudry, 2006).  Indeed, the expression and localization of the NR2 subunits 
within the synapse are developmentally regulated (Sheng et al, 1994). The 
NR2B subunit is predominant during synaptogenesis, while NR2A 
expression does not rise until later postnatal stages near the end of the 
synaptogenesis period in rodents.  The localization of the subunits is also 
developmentally regulated since increased NR2A replaces NR2B-containing 
receptors as the main NMDA-R in the synapse, and NR2B becomes 
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localized to extra-synaptic sites with its robust expression decreasing slightly 
after the end of synaptogenesis (Liu et al, 2004). 
     Whether the NMDA-R contains NR2A or NR2B subunits can influence 
neuronal survival or death.  NR2B-specific blockade has been shown to 
preclude apoptosis and necrosis after NMDA treatment, suggesting NR2B is 
involved in promoting neuronal death.  Conversely, antagonism of NR2A-
containing NMDA-Rs enhances apoptosis after NMDA, suggesting NR2A is 
involved in neuronal survival (Liu et al, 2007). The differences in neuronal 
survival due to subunit composition could stem from the coupling of 
different signaling pathways downstream of the receptor complex and/or 
differences in subcellular localization. In addition, the roles for NR2B and 
NR2A might possibly vary depending on the developmental stage and brain 
region (Lee et al, 2002, Hardingham et al, 2002).  The role of NR3 subunits 
is unclear, although reports suggest they have an inhibitory role on the 
receptor and might be important for NMDA-R signaling at early 
developmental stages (Perez-Otano and Ehlers, 2005; Yang et al, 2006; 
Corlew, 2007). 
     The NMDA-R can be regulated in several ways that affect the function 
and cell surface expression of the complex.  The receptor can be internalized 
via clathrin-dependent endocytosis (Lavezzari et al, 2004).  This route of 
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internalization is mediated by the phosphorylation state of tyrosine 1472 of 
the NR2B subunit by Src kinases (Yu et al, 1997; Prybylowski, et al, 2005; 
Zhang et al, 2008).   NR2B contains a binding sequence to the adaptor 
protein complex 2 (AP-2), which is involved in the formation of clathrin-
coated pits, and when NR2B is phosphorylated at Y1472, AP-2 cannot bind 
the subunit, and consequently the receptor is not internalized.  The retention 
of NR2B at the membrane also depends on the interactions of its CTD with 
scaffolding proteins of the post-synaptic density such as post-synaptic 
density protein 95 (PSD-95), which couples the NMDA-R to intracellular 
signaling molecules that cluster and promote stabilization of the receptor 
(Brenman et al, 1996; Sheng, 2001).  Finally, the motility of the receptor at 
the cell surface can also be determined by NR2 subunit composition, with 
NR2A-containing receptors being more stable at the synapse than NR2B-
containing ones (Groc et al, 2006).  It is possible the stability of NR2A is 
due to reduced interaction with PSD scaffolding proteins, since perturbations 
of the NR2A CTD interactions with PSD scaffold proteins does not affect its 
retention at the synapse (Groc et al, 2006).   
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1.4 NMDA-R-dependent signaling in FAS: nNOS and neurotrophic 
factors 
 
nNOS  
     Neuronal nitric oxide synthase (nNOS), the enzyme that produces nitric 
oxide (NO) in the brain, is closely localized to the NMDA-R in the post-
synaptic density.  nNOS produces NO in response to NMDA-R-mediated 
increases in Ca2+ influx (Bredt and Snyder, 1989; Garthwaite et al., 1989; 
Kornau et al., 1997; Christopherson et al., 1999).  nNOS has been implicated 
as a source of protection from ethanol-induced neurotoxicity during brain 
development.  Mice that are deficient in nNOS are more vulnerable to 
neurodegeneration after exposure to ethanol in a mouse model of FAS 
(Bonthius et al, 2006), indicating nNOS protects neurons from ethanol-
induced toxicity (Bonthius et al, 2002).  In vitro studies suggest nNOS-
mediated neuroprotection of developing neurons after ethanol is part of a 
neurotrophic survival pathway stimulated by nerve growth factor (NGF) that 
also requires CREB activation (Bonthius et al, 2003; Karacay et al, 2007).  
     nNOS possesses other neuroprotective effects in the CNS.  These include 
post-translational S-nitrosylation of the NMDA-R (Lipton and Stamler, 
1994), caspases (Kim et al, 2002; Fiorucci, 2001) and p21ras (Yun et al, 
1998; Chiueh, 1999; Ahern et al, 2002).  NO can also lead to increased 
expression of cytoprotective genes such as HSP70 (Sharp et al, 1999) and 
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Bcl-2 (Shimazaki et al, 1994; Kang et al, 2004).  Furthermore ischemic 
preconditioning-mediated neuroprotection is mediated by the NO and cyclic 
guanosine monophosphate (cGMP) pathway and new protein expression 
(Andoh, 2000; Atochin et al, 2003).  Under pathological circumstances, 
however, overproduction of NO and increased levels of reactive oxygen 
species that can lead to the formation of peroxynitrite, a reactive agent 
implicated in mechanisms of excitotoxicity after stroke (Keynes and 
Garthwaite, 2004).  S-nitrosylation and nitration of proteins by peroxynitrite 
also exacerbate neurological disorders such as dementia (Giasson et al., 
2000), Parkinson's disease (Chung et al., 2004), and Alzheimer's disease 
(Uehara et al., 2006). 
      The principal mechanism for NO action in the brain is through activation 
of cGMP, which is stimulated by calcium via calmodulin and PKG 
activation resulting in the modulation of ion channel function (Garthwaite et 
al, 1988).  Interestingly, the cGMP pathway also activates the anti-apoptotic 
serine/threonine kinase Akt by PKG-dependent activation of 
phosphatidylinositol 3-kinase (PI3 kinase) (Waxman and Lynch, 2005). S-
nitrosylation has recently emerged as a form of post-translational 
modification of ion channels, thus providing a route for NO to regulate 
electrical activity without stimulating production of cGMP. In the brain, 
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PKG and S-nitrosylation enhance the activity of large conductance Ca2+-
activated K+ (BK) channels.   
 
Neurotrophic factors: BDNF and NGF 
     As discussed previously, a great portion of the neuronal population is 
eliminated through programmed cell death in early postnatal stages during 
developmental synaptogenesis.  Neurons enter apoptosis depending on their 
proliferative or metabolic state, or the presence of extracellular signals, and 
the subset that survives, do so through their ability to effectively connect to 
appropriate targets that deliver neurotrophic factors essential for survival 
(Hidalgo, 2003; Benn et al, 2004; Buss et al, 2006), forming synapses as a 
result, and eventually, neural circuits.   
     The formation of new synapses relies on electrical activity between 
afferent and target neurons (Katz and Shatz, 1996; Komuro and Rakic, 1998; 
Penn et al., 1998; Spitzer et al., 2000; Stellwagen and Shatz, 2002), which 
allow delivery of neurotrophic support and maturation of the synapse.  This 
model of activity-dependent survival comes from in vivo and in vitro studies 
where cortical neurons have shown dependence on the activation of the 
NMDA-R and the consequent synthesis/release of BDNF for survival 
(Lessman et al, 2003; Suzuki et al, 2007).  In the human brain this process 
 12
starts in gestation and lasts for a few years after birth.  In rodents, 
synaptogenesis is solely postnatal, occurring during the first 2 weeks after 
birth.   
     Nerve growth factor (NGF) and brain-derived neurotrophic factor 
(BDNF) are indispensable during developmental, and adult synaptogenesis 
(Garofalo et al, 1992; Aguado et al, 2003).  Ethanol exposure can decrease 
the expression of BDNF and NGF, and the results vary depending on the 
manner of administration, length of exposure, brain region, and 
developmental period.  In vitro data support a neuroprotective role for 
BDNF and NGF after ethanol exposure  (Heaton et al, 1994; Climent et al, 
2002). 
     tPA can aid in the maturation of pro-BDNF and pro-NGF through the 
activation of the extracellular protease plasmin (Pang et al, 2004; Bruno and 
Cuello, 2006).  This process is essential for the formation of LTP in the adult 
hippocampus (Pang et al, 2004).  The survival-related properties of these 
neurotrophic factors are mediated by the neurotrophic tyrosine kinase 
receptors (Trk): BDNF binds TrkB and NGF binds and activates TrkA.  
However, activation of the low affinity nerve growth factor receptor (also 
known as the p75 neurotrophin receptor) by BDNF or NGF has been 
associated with apoptotic neuronal death (Huang and Reichardt, 2001).  
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1.5 Plasminogen activator inhibitor type 1 (PAI-1) in CNS physiology 
     As discussed earlier, inappropriate, elevated levels of tPA activity can 
have detrimental effects in the brain.  Plasminogen activator inhibitor type 1 
(PAI-1), a member of the serine protease inhibitor (serpin) gene family, is 
the primary inhibitor of tPA and urokinase (uPA) activity in the brain, and a 
key regulator of fibrinolysis in the vasculature.  PAI-1 irreversibly inhibits 
tPA activity and abrogates the production plasmin (Lawrence et al, 1990). 
Eventually, the tPA:PAI-1 complex can be cleared from the extracellular 
space through LRP (Cao et al, 2006).  
     Most of PAI-1 is produced by astrocytes (Buisson et al, 1998; Hino et al, 
2001), and previous work implicated astrocyte-derived PAI-1 in neuronal 
anti-apoptotic signaling (Kimura et al, 2000; Soeda et al 2001).  These 
studies established that PAI-1 deficiency, in pheochromocytoma (PC12) 
cells differentiated with NGF, resulted in a significant reduction of Bcl-2 
and Bcl-XL mRNAs, which typically promote cellular survival, and an 
increase in Bcl-XS and Bax mRNAs, which typically promote apoptosis 
(Soeda et al., 2001).  As a result, pro-apoptotic signaling was favored 
leading to cellular death.  
     Although basal PAI-1 levels are relatively low in the brain, they can 
rapidly increase upon stimulation.  An example of this is seen after intra-
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hippocampal delivery of the glutamate analog KA.  The treatment increases 
tPA activity and induces excitotoxicity in WT mice, whereas tPA-/- mice are 
protected from neuronal injury (Tsirka et al, 1995).  PAI-1 mRNA is 
upregulated following KA-induced increase in tPA activity (Masos and 
Miskin, 1997), suggesting an elevation in tPA can trigger a subsequent 
increase in PAI-1 leading to a decrease of the protease activity.  
Furthermore, when exogenous PAI-1 was administered during KA injection, 
neurodegeneration was abrogated (Tsirka et al, 1996), suggesting PAI-1 
promotes neuronal survival via inhibition of tPA.  However, since WT mice 
not infused with PAI-1 do undergo neurodegeneration after KA, it is unclear 
whether the reported increase in PAI-1 mRNA in WT reflects an increase in 
protein levels that is sufficient to abolish tPA activity in a timely manner. 
     PAI-1 has also been implicated in cellular migration and neuritogenesis 
during development.  Recent research showed stimulation of muscarinic 
receptors in astrocytes triggered the release of PAI-1, laminin, and 
fibronectin, facilitating the extension of neurites during development 
(Guizzeti et al, 2008).  In addition, PAI-1 upregulation was required for 
laminin- and fibronectin-mediated neuritogenesis.  It remained unclear 
whether the involvement of PAI-1 was dependent or independent of tPA.  It 
is possible the presence of PAI-1 in the extracellular space precludes tPA-
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mediated degradation of laminin and possibly other components of the 
matrix.  In light of tPA’s involvement in ethanol-induced neurodegeneration 
in the developing brain, we became interested in determining if PAI-1 is also 
associated to ethanol-induced neurotoxicity.  Since neuronal death plays a 
pivotal role in the development and outcome of FAS, the identification of 
the molecules that influence neurons’ vulnerability to ethanol’s effects is of 
critical importance. 
 
1.6 Chronic stress effects on hippocampal-dependent learning 
      Exposure to short-lasting stressful situations can induce plasticity 
changes in the hippocampus that are necessary for learning, and ultimately 
survival. However, the prolonged exposure to stressful stimuli can result in 
maladaptive pathological effects on the hippocampus that might lead to the 
development of anxiety disorders, posttraumatic stress disorders, and 
depression (Miller and McEwen, 2006).  Male rodents that are chronically 
stressed by immobilization (6 hours/day for 21 days) have retracted dendritic 
spines of hippocampal CA3 neurons, decreased body weight, and 
impairments in spatial memory tasks (Tsien et al, 1996; McEwen BS, 1999; 
Pawlak et al, 2005; McLaughlin et al, 2007). 
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     Chronic stress in the rat also suppresses dentate gyrus neurogenesis and 
causes dendrites of hippocampal and medial prefrontal cortical neurons to 
shrink (Gould, et al, 1998; Bennur et al, 2007; Cameron and Gould, 1994; 
Cerqueira et al, 2005; Cook and Wellman, 2004).  Interestingly, the same 
treatment increases dendritic complexity and sprouting of new synapses in 
neurons of the basolateral amygdala (Duvarci and Pare, 2007). Repeated 
stress also increases fear and aggression and reduces spatial memory (Wood 
et al, 2003; Conrad et al, 1996).  
     tPA is highly expressed in the adult hippocampus, and heavily involved 
in synaptic plasticity events that underlie learning and memory.  Basal 
extracellular tPA activity can be observed in the mouse hippocampus within 
the mossy fiber pathway, with little or no activity or expression within the 
perforant path, the Schaffer collaterals, or neuronal cell bodies (Salles and 
Strickland, 2002).  Hippocampal tPA has been implicated in LTP (Frey et 
al., 1996; Huang et al., 1996; Baranes et al., 1998; Madani et al., 1999; Pang 
et al, 2004), long-term depression (Calabresi et al., 2000), NMDA-R-
mediated signaling (Nicole et al., 2001; Norris and Strickland, 2007), and 
synaptic remodeling (Baranes et al., 1998; Neuhoff et al., 1999).  
Additionally, overexpression of tPA enhances long-term potentiation (LTP) 
and improves performance in the Morris water maze (Madani et al., 1999). 
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      tPA is a key mediator of the structural and molecular changes that ensue 
in the hippocampus as a result of repeated exposure to stressful stimuli.  
Mice deficient in tPA and plasminogen are protected from stress-induced 
decrease in NMDA-Rs and reduction in dendritic spines, and show impaired 
acquisition, but not retrieval, of hippocampal-dependent spatial learning in 
the Morris water maze (Pawlak et al, 2005).  Since tPA is a key target of the 
stress response in the hippocampus, we sought to determine if chronic stress 
regulates the tPA/PAI-1 system in this brain region.  We observed chronic 
stress modulated the tPA system in the hippocampus, and the changes 
observed were associated to impairments in learning and memory. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Animals  
C57/BL6/J WT, tPA-/-, PAI-1-/-, and Plg-/- mice backcrossed for at least 10 
generations were used in all the experiments.  Mice were maintained in the 
Comparative Bioscience Center (CBC) with a controlled humidity, 
temperature, and light/dark cycle (7:00 am to 7:00 pm light).  All animal 
procedures were according to protocols approved by the Institutional Animal 
Care and Use Committee (IACUC).  
 
2.2 Polymerase Chain Reaction (PCR) 
DNA from tail tissue was obtained at the moment of sacrifice. Tails were 
digested overnight at 55 degrees in a mix of lysis buffer & Proteinase K. 
DNA was extracted and PCR product samples run on 2% agarose gel. The 
tPA primers were: T881 TTGTGTCGTGCCAGGCCGAGTGCC, T731  
GCTATGTTGGGAAAGGTGTGACTTACCG,PGKnSATTAAGGGCCAG
CTCATTCCTCCC. PAI-1primers: 2726 
GAGTGGCCTGCTAGGAAATTCATTC,2312GACCTTGCCAAGGTGA
TGCTTGGCAAC,PGKpAAATGTGTCAGTTTCATAGCC.   
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2.3 Materials 
 Human recombinant tPA was provided by Genentech (South San Francisco, 
CA) and dissolved in phosphate buffered saline (PBS). Plasminogen for gel 
zymographies was isolated from human plasma provided by the New York 
Blood Center (Deutsch and Mertz, Science, 1970).  The tPA inhibitor, tPA-
STOP, was purchased from American Diagnostica (Stamford, CT) and the 
mutant S481A inactive tPA was obtained from Molecular Innovations 
(Novi, MI).  MK801 was purchased from Calbiochem (San Diego, CA), 
Ro25-6981 was purchased from Tocris (Ellisville, MO). Diazepam was 
purchased from Sigma (St. Louis, MO).  
 
2.4 Acute ethanol treatment  
Although synaptogenesis begins during pre-natal stages in humans, this 
process occurs post-natally in mice during the first two weeks after birth.  
Therefore pups were used at post-natal day 7 (P7) in these studies.  Pups 
were injected subcutaneously (s.c.) with two injections of 2.5g/kg ethanol 
(prepared as a 20% solution in sterile saline) at 0 hour and 2 hours.  Control 
pups were injected with an equal volume of sterile saline.   
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2.5 tPA in-gel zymography   
Forebrains from saline and ethanol-treated WT mice were removed and 
homogenized in 100 mM Tris containing 0.2% Triton X-100 and 
phosphatase inhibitors.  After protein determination by the BCA Assay 
(Pierce, Rockford, IL), the homogenates were prepared to equal 
concentrations in non-reducing loading buffer and kept on ice.  Samples 
were loaded on 10% separating gels containing casein and plasminogen.  
Upon completion, gels were rinsed in 2.5% Triton X-100 twice for 45 min at 
37oC and then incubated overnight at 37oC in 0.25% Triton X-100.  The 
following day, gels were stained with Coomassie Blue R-250 for 30 minutes 
and then destained with 10% acetic acid to visualize tPA activity.  The bands 
representing tPA activity were quantified with Scion software (NIH).  
 
2.6 in situ zymography 
To determine hippocampal extracellular tPA activity after 21 days of chronic 
restraint stress, 20 µm thick sections were incubated with an overlay mixture 
containing casein and plasminogen.  The sections were then coverslipped 
and incubated at 37° C until dark zones of lysis became visible in the 
hippocampus.  The sections were then observed in the microscope using a 
dark field setting, and pictures were taken and stored for analysis at a later 
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time.  tPA activity (lytic zones) was analyzed using Image J (NIH).  Briefly, 
the area of lysis was determined, and divided by the total hippocampal area, 
and multiplied by 100 to determine the percentage area of lysis.   
 
2.7 Fluorescent in situ zymography 
To determine extracellular tPA activity in neonatal mice after ethanol (or 
saline) exposure, 20 µm thick sections were incubated with an overlay 
mixture containing plasminogen and fluorescently quenched casein 
(Molecular Probes, Oregon), that fluoresces when cleaved by plasmin.  The 
sections were then coverslipped and incubated at 37° C for 2.  The sections 
were then observed in a fluorescent microscope (Zeiss Axioscope) using the 
fluorescein filter to visualize the areas of lysis, and pictures were taken and 
stored for analysis at a later time.  
 
2.8 Immunoprecipitation and western blotting 
Immunoprecipitation 
Samples of forebrain homogenates from ethanol- or saline-treated mice were 
adjusted to equal protein concentration and precleared with preimmune IgG 
and Gamma Bind Plus Sepharose beads (Amersham Biosciences, 
Piscataway, NJ). The monoclonal anti-NR2B antibody (NeuroMab facility, 
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UC Davis, CA) was added for 1 hr, followed by incubation with Sepharose 
beads overnight at 4°C. Beads were washed with PBS and heated to 100°C 
for 5 min in loading buffer containing DTT.  Following 
immunoprecipitation, we probed for ß-adaptin and NR2B by western blot.  
 
Western blotting  
Forebrain homogenates of saline and ethanol-treated WT and tPA-/- mice 
were prepared as described above.  All samples were prepared to equal 
amounts of protein concentration, as previously determined by BCA assay.  
After protein separation on 4-15% pre-cast gradient Tris-Glycine 
polyacrylamide gels and transfer onto nitrocellulose membranes, blots were 
blocked in 5% milk and incubated in primary antibody overnight at 4oC.  
Blots were rinsed in Tris buffered saline containing 0.1% Tween-20 (TBS-
T), and then incubated in secondary antibody for 1 hr at room temperature 
followed by rinsing in TBS-T before exposure to film.  Bands were scanned 
and quantified with the Scion software (NIH), and normalized to beta-
tubulin. 
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2.9 Antibodies 
Polyclonal anti-caspase-3 (1:500) antibody was obtained from Cell 
Signaling; monoclonal anti-cytochrome c (1:500) from BD Pharmingen; 
polyclonal anti-NGF (1:500), anti-BDNF (1:500), anti-NR1 (1:1000) and 
anti-cFOS (1:500), and ß-adaptin (1:500) were purchased from Santa Cruz 
Biotechnology; polyclonal anti-tPA from Molecular Innovations and 
American Diagnostica: polyclonal anti-phospho GAP-43 (1:1000) and anti-
GAP-43 (1:1000) from Chemicon; polyclonal anti-nNOS (1:1000) from 
Biomol; anti-cleaved caspase-3 from Cell Signaling; anti-NR1 from Santa 
Cruz Biotechnology; monoclonal anti-PSD-95 from Sigma; polyclonal anti-
NR2B from PhoshoSolutions; monoclonal anti-NR2B from the NeuroMab 
facility; polyclonal anti-phospho NR2B (Y1472) from Imgenex; and anti-
NR2A from Upstate Biotechnologies. 
 
2.10 Cleaved Caspase-3 Immunostaining  
Saline- and ethanol-treated WT and tPA-/- mice were deeply anesthetized 
and transcardially perfused with normal saline and 4% paraformaldehyde.  
Brains were removed and post-fixed in 4% paraformaldehyde for 48 hrs, 
followed by immersion in 30% sucrose until sinking.  Brains were then 
frozen, sectioned at 20 um, and mounted on slides.  The slides were allowed 
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to air-dry overnight. The following morning they were incubated in blocking 
buffer (1% BSA, 5% goat serum, 0.5% Triton X-100, in PBS) for 2 hours at 
room temperature, followed by primary antibody (anti-cleaved caspase-3 
alexa fluor 488-conjugated, Cell Signaling, 1:500) incubation in blocking 
buffer at 4°C overnight. The following morning sections were washed in 
PBS with Triton X-100, coverslipped, and observed in the fluorescent 
microscope. 
 
2.11  tPA Immunostaining 
tPA-/- P7 mice that had been treated with S481A tPA and ethanol (or saline), 
were deeply anesthetized and transcardially perfused with normal saline and 
4% paraformaldehyde.  Brains were removed and post-fixed in 4% 
paraformaldehyde for 48 hrs, followed by immersion in 30% sucrose until 
sinking.  Brains were then frozen, sectioned at 20 um, and mounted on 
slides.  The slides were allowed to air-dry overnight. The following morning 
they were incubated in blocking buffer (1% BSA, 5% goat serum, 0.5% 
Triton X-100, in PBS) for 4 hours at room temperature followed by primary 
antibody incubation (anti-tPA, Molecular Innovations 1:500; anti-tPA, 
American Diagnostica 1:500) or preabsorbed primary antibody incubation in 
blocking buffer at 4°C overnight. Preabsorbtion was done by incubation of 
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the primary antibodies with tPA-/- tissue for 4 hrs at room temperature 
(Salles and Strickland, 2002).  Slides were then washed with Triton X-100, 
and incubated with fluorescently tagged secondary antibody. After 
incubation, the sections were washed coverslipped, and observed in the 
fluorescent microscope. 
 
2.12 PAI-1 Enzyme-Linked Immuno Sorbent Assay (ELISA)   
Forebrain homogenates from saline- and ethanol-treated WT mice were 
prepared as described above.   Samples were prepared in duplicates (200 ug 
of protein each) and the ELISA was performed using a kit (Molecular 
Innovations, Novi, MI) according to the manufacturer’s instructions. 
 
2.13 Fluoro-Jade B staining  
Mice were deeply anesthetized and transcardially perfused with normal 
saline and 4% paraformaldehyde.  Brains were removed and post-fixed in 
4% paraformaldehyde for 48 hrs, followed by immersion in 30% sucrose 
until sinking.  Brains were then frozen and sectioned at 40 um on a cryostat.  
Sections were collected in PBS, mounted on slides, and allowed to air dry 
for 24 hrs.  After drying, the slides were stained with Fluoro-Jade B (FJB) as 
has been previously described (Schmued and Hopkins 2000; Toscano et al. 
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2008). FJB detects neuronal damage by staining neurons undergoing 
necrosis or apoptosis a fluorescent green color. 
 
2.14 Fluoro-Jade B quantitation and analysis  
Quantitation was done as described previously (Paul et al, 2007).  Upon 
completion of FJB staining the slides were observed on the fluorescent 
microscope with the appropriate filter. All pictures from animals from the 
same experiment were taken the same day with the same exposure settings.  
A minimum of 3 slices per animal and brain region was used for 
quantification purposes. Images taken with the 20X objective were obtained 
using a camera attached to the microscope and stored for later analysis. 
Image J (NIH software) was used to quantify FJB-positive staining.  Images 
of the area of interest (e.g cingulate cortex, hippocampus, thalamus) were 
converted to 1-bit, the background substracted from the image, and the 
positive-labeled cells counted by the program.  
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2.15 Blood Ethanol level determination   
Plasma EtOH levels were analyzed with the EnzyChrome kit by BioAssay 
Systems according to the manufacturer’s directions.  
  
2.16 Evans Blue extravasation 
Neonatal P7 and adult P90 WT and tPA-/- mice were injected transcardially 
with a solution of 2% Evans blue/PBS (4 ml/kg) dye, or control buffer.  
Fifteen minutes after Evans blue injection, animals were perfused with PBS, 
and their brains collected for analysis.  The brains were sectioned in a 
freezing cryostat and observed in the fluorescent microscope, the presence of 
Evans Blue was observed in the brain parenchyma of young, but not the 
adult animals.  
 
2.17 Restraint stress 
Adult (10-12 weeks of age) WT, tPA-/-, and PAI-1-/- mice were immobilized 
in wire mesh restrainers and placed in their homecage.  Chronic stress lasted 
6 hours a day, for 21 consecutive days.  The restrainers were secured with 
clips to avoid having the mice escape from them.  On an occasion, a mouse 
bit through the restrainer and escaped immobilization, this mouse was 
sacrificed and eliminated from the study.  Control animals were not 
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restrained, and were kept in a different room than stress mice.  We fed, 
changed water bottles, and cleaned their cages in order to minimize 
unnecessary stress by the CBC staff. 
 
2.18 Fear Conditioning  
Fear conditioning was done on adult mice (8-10 weeks of age) that had been 
exposed to ethanol or saline at P7.  In a separate study, chronically stressed 
(or non-stressed control) mice, were also tested in this paradigm.  The 
conditioning chambers were equipped with a speaker, house light, and a 
video camera. The chamber floors consisted of rods that were connected to a 
shock generator.  Mice were habituated to the behavioral room for 1 hour on 
the day of training and placed individually into a conditioning chamber 
cleaned with an ammonia-based solution for 2 minutes, this time was 
considered the “baseline period”.  Mice were then exposed to three tone-
footshock pairings (tone, 20 sec, 85 dB, 3.5 kHz; footshock, 1 sec, 0.6 mA) 
with an inter-trial interval of 60 sec.  Upon completion of training, mice 
were returned to their home cages and room and tested 24 hrs later.  The 
training sessions were video recorded in order to analyze the animals’ 
baseline freezing behavior (every 5 sec) during training.  On testing day, 
mice were habituated to the behavioral room for 1 hr.  Mice were then 
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placed individually into the same chamber (same scent, lighting, etc.) as the 
previous day for a 2-minute period, during which time their behavior was 
recorded.  Freezing behavior, or the complete lack of movement, in response 
to the context, was scored every 5 sec.  
 
2.19 Statistical analyses  
Data are presented as mean ± SEM. Between-group comparisons were 
performed with factorial ANOVA and Tukey post-test.  P values <0.05 were 
considered significant. Numbers of animals in each experiment and the 
statistical significance are presented in figure legends. 
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CHAPTER 3: RESULTS 
3.1 Ethanol treatment increased neuronal-associated tPA activity in 
perinatal mouse pups 
     tPA and PAI-1 activities were determined following the administration of 
sedating doses of ethanol (2.5 g/kg at 0hr and 2 hr) to wild-type (WT) mouse 
pups postnatal day 7 (P7).  Gel zymography of forebrain homogenates showed 
tPA activity slightly, but not significantly, increased 30 minutes after ethanol 
intake (Figure 1A and 1C).  Three hours post-ethanol administration tPA 
activity was significantly elevated over 1.5 fold above control levels. tPA 
activity peaked with a 2-fold increase at 6 hours, and continued to be 
significantly increased at 24 hrs (Figure 1B and 1C) following ethanol 
administration.   Increased tPA activity, represented as green fluorescence, was 
visibly localized to the cortex, hippocampus, and thalamus of WT mice treated 
with ethanol using in situ zymography, which detects extracellular activity of 
the protease, 3 hours post-ethanol. (Figure 1D, 1E, and 1F respectively).   
Localized increase of tPA activity could be the result of upregulation of 
tPA expression or a decrease in PAI-1 expression.  Therefore, tissue 
homogenates from WT P7 mice treated with ethanol were also examined for the 
expression of free and complexed (i.e. total) PAI-1 using an enzyme-linked 
immunosorbent assay (ELISA).   PAI-1 antigen was increased approximately 3-
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fold above baseline levels in the WT brain 30 minutes after ethanol treatment, 
but was reduced to baseline at 3 hours, and downregulated below the baseline 
by 24 hours following the administration of ethanol (Figure 1G). The pattern of 
neurotoxic insult after ethanol leading to elevated tPA activity and increased 
PAI-1 is not consistent with the pattern previously observed by Masos and 
Miskin in adult mice following kainic acid (KA) treatment (Masos and Miskin, 
1997).  In the KA scenario, the hippocampal increase in tPA was followed by a 
subsequent increase in PAI-1.  Here we observe an opposite pattern where 
ethanol increased PAI-1 levels prior to the increase of tPA activity.  Also, 
ethanol induced downregulation of PAI-1 below the baseline 24 hours after 
treatment when tPA levels remain significantly elevated. 
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Figure 1. Ethanol treatment increased neuronal-associated tPA activity 
in perinatal mouse pups. WT mice (P7) were injected subcutaneously (s.c) 
with ethanol (referred to as EtOH in the figures) in 2 doses of 2.5g/kg at 
times 0 hr and 2hr (N=5-6). Control mice were injected with equal volumes 
of saline.  Mice were sacrificed at different time-points, the forebrain was 
homogenized, and tPA activity assayed by in-gel zymography (A and B) and 
in situ zymography (D, E, F).  Quantification of gel zymographs (C) showed 
tPA activity was significantly increased in the forebrain of WT mice 3 hr 
after EtOH (*, P < 0.05).  tPA activity remained increased at later time-
points up to 24 hrs (**, P < 0.001).  In situ zymography showed extracellular 
tPA activity is localized to the cortex (D), thalamus (E), and hippocampus 
(F) of WT mice 3 hrs after ethanol, as observed by green fluorescence (blue 
is DAPI staining).  PAI-1 was assayed with an ELISA. PAI-1 levels were 
increased significantly (***, P< 0.0001) 0.5 hr after treatment, returned to 
baseline at 3 hr post-ethanol, and were downregulated (*, P < 0.05) 24 hrs 
post-ethanol.     
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Figure 1 
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3.2 tPA upregulation corresponds to increased apoptotic 
neurodegeneration after ethanol       
Increased tPA activity promotes excitotoxin-induced neurodegeneration 
as seen following kainic acid treatment and ethanol withdrawal seizures in the 
hippocampus of adult mice.  To determine whether the increased tPA activity 
seen in P7 mouse brain following ethanol treatment was similarly associated 
with neuronal loss, we used Fluoro-Jade B staining to identify areas of 
neurodegeration in WT and tPA-/- mice 24 hours after ethanol treatment. 
Neuronal loss was widespread throughout the WT forebrain (Figure 2 and 
Figure 3).  The most vulnerable areas included the cingulate cortex which 
exhibited ~120-fold increase in neuronal loss above saline-treated controls 
(Figure 2A and 2D), and the thalamus with ~150-fold increase in 
neurodegeneration above control (Figure 3A and 3D).  In a stark contrast, tPA-/- 
mice showed significant attenuation in neuronal loss in both the cortex (Figure 
2C and 2F) and thalamus (Figure 3C and 3F) after ethanol treatment.  
The effect of tPA on neurodegeneration as detected by Fluoro-Jade B 
staining was gene dosage-dependent, as tPA mice heterozygous for tPA 
deficiency showed an intermediate phenotype in both the cortex (Figure 2B and 
2F) and thalamus (Figure 3B and 3F) when compared to WT and tPA-/- animals. 
Ethanol induced a ~3.6-fold increase in neurodegeneration in the WT 
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hippocampus  (Figure 4A and 4E) compared to a ~0.8-fold increase seen in the 
tPA-/- (Figure 4B and 4E).  The absence of significant neuronal death in the 
hippocampus observed in this study is consistent with previous studies of FAS 
in neonatal mice (Ikonomidou et al, 2000) in which the same protocol did not 
affect the hippocampus to the same magnitude it did the cortex and thalamus.   
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Figure 2.  Ethanol induces neurodegeneration in the cortex of WT mice, 
but not tPA-/-.  WT, tPA-/-, and tPA+/- P7 mice were injected with ethanol or 
saline as control (N = 6-7/group).  24 hrs after treatment, animals were 
sacrificed and brain sections analyzed histologically with Fluoro-Jade (FJB) 
to visualize neurodegeneration.  Ethanol induced extensive neuronal death in 
the cortex of WT (A) when compared to saline-treated mice (D) (***, P < 
0.0001).  tPA-/- mice, however, are significantly protected from 
neurodegeneration after ethanol (C) in comparison to the saline group (F) (*, 
P < 0.05).  tPA+/- showed intermediate neurodegeneration (B) when 
compared to the WT (A) and tPA-/- (C) brains after ethanol (**, P < 0.001).  
There was no difference in basal (saline-treated) neurodegeneration between 
any of the groups. 
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Figure 3. Ethanol induces neurodegeneration in the thalamus of WT 
mice, but not tPA-/-. WT, tPA-/-, and tPA+/- P7 mice were injected with 
ethanol or saline as control (N = 6-7/group).  24 hrs after treatment, animals 
were sacrificed and brain sections analyzed histologically with Fluoro-Jade 
(FJB) to visualize neurodegeneration.  Ethanol induced extensive neuronal 
death in the thalamus of WT (A) when compared to saline-treated mice (D) 
(***, P < 0.0001). tPA-/- mice, however, are significantly protected from 
neurodegeneration after ethanol (C) in comparison to the saline group (F) (*, 
P < 0.05).  tPA+/- showed intermediate neurodegeneration (B) when 
compared to the WT (A) and tPA-/- (C) brains after ethanol (**, P < 0.001). 
There was no difference in basal (saline-treated) neurodegeneration between 
any of the groups. 
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Figure 4. Ethanol induces neurodegeneration in the hippocampus of 
WT mice, but not tPA-/-. WT and tPA-/- P7 mice were injected with ethanol 
or saline as control (N = 6-7).  24 hrs after treatment, animals were 
sacrificed and brain sections analyzed histologically with Fluoro-Jade (FJB) 
to visualize neurodegeneration.  Ethanol induced modest, but significant 
neuronal death in the hippocampus of WT (A) when compared to saline-
treated mice (C) (*; P > 0.05).  tPA-/- mice did not display significant 
neurodegeneration in the hippocampus after ethanol (B) either (P > 0.05). 
There was no difference in basal (saline-treated) neurodegeneration between 
any of the groups. 
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It was possible that the difference in neurodegeneration during 
synaptogenesis in tPA-/- and wild type could have been an artifact of differing 
blood ethanol concentrations, perhaps reflective of underlying metabolic 
differences between the two genotypes, and not to a primary difference in 
neuronal physiology.  To address this possibility, we determined the blood 
ethanol concentrations following treatment with the acute binge paradigm 
described earlier (2.5g/kg ethanol at 0 and 2 hours).  We found no difference in 
blood ethanol concentrations between tPA-/- and WT mice (Figure 5) at any 
timepoint studied.  This result verifies that the observed neuroprotection in the 
tPA-/- mice was not due to differences in the rate of ethanol metabolism between 
mouse genotypes.     
 
 
Figure 5. Blood ethanol concentrations are similar in WT and tPA-/- 
pups.  WT and tPA-/- P7 mice were injected with ethanol as previously 
described.  Mice were decapitated at different time-points after treatment, 
trunk blood was collected, and plasma was assayed to determine ethanol 
concentration.  WT and tPA-/- mice show similar concentration of ethanol in 
plasma at all the time-points evaluated. (P > 0.05) 
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Ethanol-induced apoptotic neurodegeneration during synaptogenesis is 
mediated by BAX, requires the release of cytochrome c from the mitochondrial 
membrane, and culminates with the activation of caspase-3 (Olney et al, 2000 
and 2002; Young et al, 2003 and 2005).  To determine if activation of ethanol-
induced apoptosis during synaptogenesis is tPA dependent, we examined tissue 
homogenates and sections for cleaved caspase-3 and cytochrome c 
immunoreactivity.  WT mice showed an increase in activation of caspase-3 as 
observed by western blot (Figure 6A and 6B) and immunohistochemistry 
(Figure 6C), and cytochrome c immunoreactivity (Figure 6E) eight hours after 
ethanol treatment as previously noted (Olney et al, 2000 and 2002; Young et al, 
2003 and 2005).  tPA-/- mice did not exhibit changes in active caspase-3 (Figure 
6A, 6B, and 6D) or cytochrome c (Figure 6F) immunoreactivity concomitant 
with the lack of neuronal loss observed in these mice. 
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Figure 6. Ethanol induces caspase-3 activation and cytochrome c 
immunoreactivity in WT, but not tPA-/- mice. WT and tPA-/- P7 mice were 
injected with ethanol or saline and sacrificed 8 hrs post-treatment.  Ethanol 
induced the activation of caspase-3 in the forebrain of WT mice (**, P < 
0.001) but this activation was not seen in the tPA-/- (A and B). 
Immunohistochemistry showed ethanol dramatically increased caspase-3 
and cytochrome-c reactivity (C and E) in WT mice, but not tPA-/- (D and F).   
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In case tPA-/- mice were resistant to ethanol-induced neurodegeneration 
as a result of underlying developmental abnormalities distinct from the acute 
ethanol insult and not as a direct effect of tPA activity upregulation following 
ethanol ingestion, we used the small molecular weight tPA-specific inhibitor 
tPA-STOP to deplete tPA activity (Figure 7I and 7K) instead of making use of 
genetically deficient tPA mice. WT mice were injected intra-peritoneally (i.p.) 
with tPA-STOP (10ug/g) 30 minutes before the first ethanol treatment.  Fluoro-
Jade B staining showed that the mice pre-treated with tPA-STOP exhibited 
reduced neurodegeneration after ethanol when compared to the group treated 
only with ethanol (Figure 7).  The cingulate cortex showed ~80 fold reduction 
in neurodegeneration when compared to the ethanol-treated group (Figure 7B 
and 7G).  The thalamus showed greater reduction in neuronal loss than the 
cortex ~100 fold (Figure 7E and 7H).  Forebrain samples collected from WT 
mice treated with both tPA-STOP and ethanol did not have as extensive an 
upregulation of tPA activity compared to WT mice that did not receive tPA-
STOP at 3 and 6 hrs post-Ethanol (Figure 7J and 7L).  This result is consistent 
with that seen using tPA-/- mice and suggests that the effect of tPA in ethanol-
induced neurodegeneration is an acute effect of tPA upregulation. 
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Figure 7. tPA-STOP attenuates ethanol-induced neurodegeneration in 
WT mice. WT P7 mice were injected with tPA-STOP (10ug/g body weight) 
30 mins prior to the first ethanol injection.  tPA-STOP pre-treated mice 
exhibited reduced neurodegeneration when compared to mice treated with 
EtOH alone.  tPA-STOP attenuated neurodegeneration by ~80 fold in the 
cortex (A, B, and G; ***, P < 0.0001) and over 100 fold in the thalamus (D, 
E, and H; ***, P < 0.0001).  tPA-STOP administered along with saline did 
not result in any changes in neurodegeneration (C and F). 1 ng of active tPA 
was incubated with 14 ug of tPA-STOP (1ug/ul) for 3 hrs at room 
temperature.  tPA activity was reduced by ~60% (I and K).  Mice pre-treated 
with tPA-STOP were sacrificed 3 and 6 hrs post-EtOH, their forebrains 
removed, and the homogenates assayed for tPA activity by in-gel 
zymography (J).  Mice pre-treated with tPA-STOP before EtOH showed an 
attenuated increase in tPA activity compared to what was previously 
observed when treated with EtOH alone (L; * P < 0.05, *** P < 0.0001). 
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Figure 7 
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3.3 tPA induction of neurodegeneration is plasminogen-independent 
The mechanisms by which tPA has previously been shown to induce 
neurodegeneration include 1) activation of plasminogen to plasmin with 
subsequent proteolysis of the supporting extracellular matrix surrounding 
neurons: 2) microglial activation: and 3) via direct modification of the NMDA-
R.  We observed increased CD11b immunoreactivity, characteristic of 
microglia reactivity, in the cortical (Figure 8C) and thalamic (Figure 8G) 
regions of WT, but not tPA-/- mice (Figure 8D and 8H) 24 hrs after ethanol 
exposure.  To determine whether tPA activation of plasminogen to plasmin was 
necessary for tPA-induced neurodegeneration in our system, plasminogen-
deficient mice (Plg-/-) mouse pups were treated with ethanol at postnatal day-7, 
and examined for neurodegeneration as previously done with tPA-/- and wild 
type animals.  There was no difference between the extent of neurodegeneration 
in Plg-/- and wild type mice (Figure 9), suggesting that tPA acts independently 
of plasmin in this system. 
 46
 
 
Figure 8. WT mice, but not tPA-/-, show increased CD11b 
immunoreactivity after ethanol.  WT and tPA-/- P7 mice treated with 
ethanol or saline (N = 6-7) were sacrificed 24 hrs after treatment, and their 
brains examined histologically for a marker of microglial activation.  WT 
mice showed enhanced immunoreactivity to an anti-CD11b FITC-
conjugated antibody 24 hrs after ethanol treatment in the cortex (C) and 
thalamus (G).  tPA-/- mice did not show increased immunoreactivity after 
ethanol in either brain region (D and H).  There were no baseline differences 
in CD11b immunoreactivity in any group (A, B, E, F).  
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Figure 9. tPA-mediated neurodegeneration after ethanol is plasmin-
independent.  To investigate if tPA-mediated neuronal death after ethanol is 
plasmin dependent, we injected WT and plasminogen-deficient (Plg-/-) P7 
mice with ethanol or saline as control (N = 6/group).  24 hrs after treatment, 
animals were sacrificed and brain sections analyzed histologically with 
Fluoro-Jade (FJB) to visualize neurodegeneration.  Ethanol induced 
extensive neuronal death in the cortex (A) and thalamus (B) of WT mice.  
Plg-/- deficient mice showed ethanol-induced neurodegeneration in the cortex 
(C) and thalamus (D) to a similar degree and pattern previously observed in 
the WT mice. There was no difference in basal (saline-treated) 
neurodegeneration between any of the groups. 
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3.4 tPA induction of neurodegeneration is independent of its proteolytic 
activity 
     To determine if restoration of tPA antigen to tPA-/- mice was sufficient to 
restore neurodegeneration as observed in the WT mouse after ethanol exposure, 
we treated P7 tPA-/- mice with exogenous tPA.  Since P7 mice cannot undergo 
stereotaxic surgery, and peripherally circulating active tPA can compromise the 
integrity of the blood brain barrier (BBB) (Yepes et al, 2003), we opted for 
peripheral administration of tPA which has a mutation from serine to alanine at 
residue 481 (S481A). This mutation renders the proteinase catalytically inactive 
(see Figure 10G) and (Olson et al, 2001).  tPA-/- mice were injected with S481A 
tPA (1µg/g) 30 minutes before the first ethanol treatment.  Fluoro-Jade B 
analysis revealed a partial, but significant, restoration of the ethanol-induced 
neurodegeneration in the tPA-/- mice that were pre-treated with S481A tPA 
(Figure 10).  The effect was surprisingly greater in the cortex with a ~80-fold 
increase (Figure 10B and 10E) than in the thalamus where the increase was in 
neuronal death was ~50-fold (Figure 10D and 10F). To verify that S481A 
reached the brain parenchyma in our P7 mice, we examined S481A-treated P7 
tPA-/- mouse brain sections by immunohistochemistry (IHC). The commercially 
available antibodies against tPA were not specific when observed by western 
blot (data not shown) and IHC, yielding high cross-reactivity with a milieu of 
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other molecules (Figure 10L). When the antibody was incubated with a tPA-/- 
forebrain slice at room temperature for 4 hrs the specificity of the antibody 
greatly increased (Figure 10M).  Our results show there was positive staining 
for tPA in the brain of tPA-/- mice treated with S481A (Figure 10H and 10I) but 
not in the tPA-/- brain of mice treated with saline (Figure 10M). 
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Figure 10. S481A tPA partially restores ethanol-induced 
neurodegeneration in the tPA-/- mouse.  tPA-/- P7 mice were injected with 
S481A tPA (1ug/g) 30 mins prior to ethanol exposure. Mice were also 
injected with saline as a control, or with ethanol alone.  Mice pre-treated 
with S481A tPA before ethanol showed a partial restoration of 
neurodegeneration (B and D) when compared to mice treated with ethanol 
alone (A and C).  Significant FJB-positive staining was seen in the cortex (B 
and E; ***, P < 0.0001) and thalamus (D and F; ***, P < 0.0001) of tPA-/- 
mice pre-treated with S481A tPA prior to ethanol. S481A tPA lacked 
enzymatic activity when compared to the same amount of active tPA by in-
gel zymography (G).  S481A tPA could be observed in the brain of tPA-/- 
mice with an anti-tPA that had been pre-adsorbed in tPA-/- tissue (H and I). 
We did not observe immunoreactivity when the 1º antibody was not present 
(J).  When the anti-tPA antibody was not pre-adsorbed, immunostaining of 
saline treated tPA-/- samples was non-specific (L).  Specificity greatly 
increased when the antibody was pre-adsorbed as seen by the reduction in 
background intensity (M). 
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Figure 10 
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This result is particularly interesting because the blood brain barrier 
(BBB) does not permit the entrance of macromolecules into the brain and raises 
the question of whether there might be an activity-independent transport 
mechanism for tPA.  An alternative possibility was that the BBB is 
incompletely developed in P7 mice facilitating passive transport of S481A tPA 
(Risau et al, 1994; Xu et al, 1993; Butt et al, 1990).  To determine which of 
these possibilities was the case, BBB permeability was examined in P7 and P90 
mice that were injected transcardially with Evans Blue, a dye with high affinity 
for albumin, which does not cross the mature BBB under physiologic 
conditions.  Fifteen minutes after Evans Blue injection, mice were perfused 
with PBS, their brains collected and sectioned in a freezing cryostat, and the 
sections examined by fluorescent microscopy.  Evans Blue dye was observed in 
the brain parenchyma of the P7 WT and tPA-/- mice (Figure 11A and 11B), but 
not of the adult P90 mice (Figure 11C and 11D).  As expected, the mice 
injected with saline were not positive for Evans Blue (Figure 11E and 11F).   
These data suggest the BBB was incomplete at the younger age, and tPA 
transport into the CNS parenchyma was not the result of a tPA-specific 
transporter.   
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Figure 11. The P7 mouse blood brain barrier is permeable to Evans 
Blue extravasation.  Since peripherally administered S481A tPA reached 
the brain parenchyma, we sought to determine the permeability of the blood 
brain barrier (BBB) in P7 mice using Evans Blue (EB).  We observed the 
presence of EB (red fluorescence) in the ventricle of tPA-/- mice (A and B), 
around the hippocampal formation (C), and around the cortex (D).  There 
was no EB fluorescence in the untreated P7 tPA-/- ventricle (E). Adult tPA-/- 
treated with EB did not show its presence in the cortical area (F). (Blue is 
DAPI staining) 
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3.5 tPA promotes neurodegeneration by downregulating neurotrophic 
factor expression following ethanol ingestion       
     Brain derived neurotrophic factor (BDNF) and nerve growth factor (NGF) 
promote neuronal growth and survival through activation of the TrkB receptor, 
and are of particular importance during early developmental stages of synapse 
formation (for reviews see Luikart and Parada, 2006; Nagappan and Lu, 2005). 
tPA can convert pro-BDNF and pro-NGF to their mature forms through the 
activation of the extracellular protease plasmin (Pang et al, 2004; Bruno and 
Cuello, 2006).  We observed ethanol treatment significantly increased the 
protein levels of both NGF 1.5-fold and BDNF 1.5-fold in the tPA-deficient 
pups 24 hours after treatment (Figure 12).  The effect of was opposite in WT 
mice, ethanol decreased NGF and had no effect on BDNF (Figure 12).  
Interestingly, WT pups showed higher baseline protein levels of NGF than tPA-
/- (Figure 12).  These data suggest that prolonged and elevated levels of tPA 
activity in the WT brain after ethanol might lead to inappropriate processing of 
pro-BDNF and pro-NGF, perhaps leading to their degradation.  However, since 
tPA-mediated neurotrophic maturation requires plasmin, and Plg-/- mice show a 
phenotype after ethanol that resembles WT, it is more likely the changes in 
BDNF and NGF observed are due to proteolysis-independent effects of tPA. 
 55
 
 
Figure 12. Ethanol increases forebrain neurotrophic factor expression 
in the absence of tPA. WT and tPA-/- P7 mice were treated with ethanol or 
saline and sacrificed 24 hrs later. The brains were removed and the 
forebrains homogenized and analyzed by western blot for BDNF and NGF 
levels (A).  Baseline levels of BDNF were similar in both genotypes, while 
NGF was initially higher in the WT than in the tPA-/- (A).  Ethanol 
significantly increased both BDNF and NGF in the tPA-/-, but not the WT 
(B). The effect was stronger for NGF (**, P < 0.001) than BDNF (*, P < 
0.05) in the tPA-/- brain.  BDNF remained the same after ethanol in the WT, 
and NGF was downregulated below the baseline (*, P < 0.05). 
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3.6 Ethanol does not suppress synaptic activity markers in the tPA-/- mice 
     One mechanism by which NGF may protect against neurodegeneration is via 
induction of nitric oxide (Bonthius et al, 2003). Nitric oxide (NO) has recently 
been shown to protect against ethanol-induced damage in the developing brain 
(Bonthius et al, 2002 and 2006) via a cGMP/PKG pathway. NO is produced by 
neuronal nitric oxide synthase (nNOS) after calcium induced activation of 
calmodulin.  Mice deficient in nNOS exhibited increased vulnerability to 
ethanol-induced neurodegeneration, particularly in the cingulate cortex and 
nuclei of the thalamus (Bonthius et al, 2006), which were the brain regions of 
most interest to us.  In our experimental paradigm, nNOS levels were 
significantly increased in tPA-/- mice, but not WT, 24 hrs after ethanol treatment 
(Figure 13A and 13B).  This suggests that there might have been a 
neuroprotective pathway in the tPA-/- mice that included both NGF and nNOS.     
     The immediate early gene c-fos encodes a transcription factor induced by 
neuronal activity that is critical in regulating neuronal cell survival.  Mice in 
which c-fos expression is largely eliminated in the hippocampus show 
decreased BDNF transcription and protein expression, more severe KA-induced 
seizures, increased neuronal excitability and neuronal death than control mice 
(Zhang et al, 2002).  We found that 8 hours after treatment, when ethanol levels 
in the circulation are still significantly elevated, the expression of cFOS was 
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suppressed in the forebrain of WT mice (Figure 13C and 13D).  The tPA-/- mice 
showed elevated expression of cFOS after ethanol treatment (Figure 13C and 
13D).   
     Another molecule of interest was the growth and plasticity associated protein 
43 (GAP-43), a neuronal protein with a critical role in axon guidance during 
synaptogenesis, as phosphorylation of GAP-43 on Ser41 by PKC promotes 
cytoskeletal remodeling (Widmer and Caroni, 1993; Aigner et al., 1995). 
Phosphorylated GAP-43 (Ser 41) was significantly increased above control 
levels in the tPA-/-, but not in WT, 24 hrs after ethanol treatment (Figure 13A 
and 13B).  However, total levels of GAP-43 remained unchanged in both 
genotypes and treatment groups (data not shown).  These results suggest 
ethanol is not properly inhibiting synaptic activity in the tPA-/- mice, as the 
neuroprotective properties of these molecules depend on excitatory, calcium-
dependent signaling pathways.  Consistent with our results, recent research 
shows NMDA-induced currents were larger in tPA-/- cortical neurons than in 
WT mice (Park et al, 2008), giving support to the idea that tPA regulates the 
NMDA-R.  
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Figure 13. Ethanol does not suppress synaptic activity markers in the 
tPA-/- mice.  WT and tPA-/- P7 mice were treated with ethanol or saline and 
sacrificed 8 hrs and 24 hrs later. The brains were removed and the forebrains 
homogenized and analyzed by western blot for cFOS expression 8 hrs after 
ethanol treatment, and for phospho-GAP-43 and nNOS 24 hrs post-ethanol. 
Baseline levels of all molecules were similar in both genotypes. Ethanol 
significantly increased both phospho-GAP-43 and nNOS in the tPA-/-, but 
not the in WT (A and B). The effect was stronger for nNOS (**, P < 0.001) 
than phospho-GAP-43 (*, P < 0.05) in the tPA-/- brain.  nNOS and phospho-
GAP-43 remained the same after ethanol in the WT mouse.  cFOS 
expression was evaluated 8 hrs after ethanol exposure (C).  Expression of 
cFOS was higher in the tPA-/- mouse than the WT (D) (*, P < 0.05). 
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3.7 tPA promotes neurodegeneration via the NMDA-R 
     Ethanol decreases synaptic activity by a dual mechanism that involves 
inhibition of the NMDA-R, and potentiation of the GABAA-R. To determine 
which neurotransmitter system mediates tPA’s effects after ethanol, we injected 
WT and tPA-/- mice with high doses of either Diazepam (30 mg/kg; GABAA-R 
agonist) or MK801 (1.5mg/kg; non-selective antagonist of NMDA-R) and 
analyzed neuronal loss 24 hours after injection.  As previously reported 
(Ikonomidou et al, 2000), both Diazepam and MK801 treatment induced 
extensive neuronal death in the developing WT cortex (Figure 14A, 14B, and 
14I), and thalamus (Figure 14C, 14D, and 14I). tPA-/- mice showed neuronal 
death after Diazepam in the cortex (Figure 14E and 14J) and thalamus (Figure 
14G and 14J), though to a significantly lesser degree than the WT.  tPA-/- mice 
demonstrated neuroprotection after MK801 (Figure 14F, 14H, and 14J), 
suggesting tPA effects on neurodegeneration are mediated by the NMDA-R. 
 
 
 
 
 
 
 60
  
 
 
 
 
Figure 14.  tPA promotes neurodegeneration via the NMDA-R.  WT and 
tPA-/- P7 mice were injected with the non-selective NMDA-R antagonist 
MK801 (1.5mg/kg) or the GABAA-R agonist Diazepam (30mg/kg). Control 
mice were injected with saline as (N = 6/group).  24 hrs after treatment, 
animals were sacrificed and brain sections analyzed histologically with FJB 
to visualize neurodegeneration.  Diazepam induced induced extensive 
neuronal death in the cortex (A) and thalamus (C) of WT when compared to 
saline-treated mice (***, P < 0.0001).  Diazepam also induced 
neurodegeneration in the cortex (E) and thalamus (G) of tPA-/- mice, albeit to 
a significantly lesser degree than WT mice. WT mice were also vulnerable 
to NMDA-R-induced neurodegeneration since MK801 treatment resulted in 
increased FJB-positive staining in the cortex (B) and thalamus (D) (***, P < 
0.0001).  tPA-/- mice, however, were significantly protected from NMDA-R-
mediated neuronal death since MK801 did not increase FJB staining in the 
cortex (F) or thalamus (H) of these mice (P > 0.05). 
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Figure 14 
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     Since NR2B is the prominent NR2 subunit during synaptogenesis, and 
results from prior studies suggest that tPA can interact with NR2B in the adult 
brain (Pawlak et al, 2005; Norris and Strickland, 2007), we examined 
neurodegeneration after treatment with the NR2B-specific antagonist Ro25-
6981 (6mg/kg) in WT and tPA-/- P7 pups.  Neurodegeneration was observed in 
the cortex (Figure 15A and 15I) and thalamus (Figure 15C and 15I) of WT mice 
after drug treatment.  tPA-/- mice were protected from Ro25-6981 
neurodegeneration (Figure 15E, 15G, 15J).  We wondered if a combination of 
Ro25-6981 and ethanol would augment neurodegeneration in the WT mice.  
Pups were treated with Ro25-6981 (6mg/kg) 30 minutes prior to treatment with 
ethanol.  Ethanol potentiated Ro25-6981-induced neurodegeneration in the 
cortex (Figure 15B and 15I) and thalamus (Figure 15D and 15I). Next, we 
administered the same combination of treatments to the tPA-/- pups as an 
attempt to potentiate inhibition of the NMDA-R neurotransmitter system in 
these mice.  tPA-/- mice were still protected from neurodegeneration even in 
these conditions (Figure 15F, 15H, and 15J), suggesting tPA promotes 
neurodegeneration via an NR2B-dependent mechanism.  
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Figure 15. tPA-/- mice are resistant to NR2B-mediated neuronal death.  
WT and tPA-/- P7 mice were injected with either a NR2B selective NMDA-
R antagonist Ro25-6981 (6mg/kg), a combination of Ro25-6981 (6mg/kg) 
administered 30 mins prior to acute ethanol binge treatment (2.5g/kg at 0hr 
and 2hr). Control mice were injected with saline as (N = 5/group).  24 hrs 
after treatment, animals were sacrificed and brain sections analyzed 
histologically with FJB to visualize neurodegeneration.  Ro25-6981 induced 
extensive neuronal death in the cortex (A) and thalamus (C) of WT when 
compared to saline-treated mice (***, P < 0.0001).  When Ro25-6981 was 
administered with ethanol neurodegeneration was increased in the cortex (B) 
and thalamus (D) (***, P < 0.0001). tPA-/- mice, however, were protected 
from NMDA-R-mediated neuronal death after administration of Ro25-6981 
on its own (E and G) or in combination with ethanol (F and H). 
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Figure 15 
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3.8 Ethanol differentially modulates the NMDA-R in WT and tPA-/- mice 
      Since tPA-/- mice were protected from NMDA-R-mediated 
neurodegeneration, we determined the expression levels of individual NMDA-R 
subunits in tPA-/- and WT P7 pups before and after ethanol treatment.  Western 
blot analysis of forebrain homogenates showed no differences in NR1 
expression between genotypes before and after ethanol (Figure 16A and 16B).  
NR2B baseline levels were also similar in tPA-/- and WT early postnatal aged 7 
mice. (Figure 16A and 16C).  However, NR2B was upregulated 24 hours after 
ethanol-treatment in tPA-/- mice, but not wild type mice (Figure 16D and 16E). 
Baseline NR2A levels were higher in the tPA-/- brain than in the WT (Figure 
16F and 16G), and ethanol treatment further augmented NR2A expression in 
the tPA-/- 24 hrs after treatment (Figure 16F and 16H).  It has been postulated 
that NR2A and NR2B can have different and opposing roles in the adult brain.  
NR2A has been shown to activate survival-signaling pathways, whereas NR2B 
activates cell death pathways (Liu et al, 2007). It might be possible then that at 
P7, enhanced baseline NR2A expression, and subsequent ethanol-induced 
increase in NR2B in the neonatal tPA-/- brain, may be part of the observed 
neuroprotection from NMDA-R mediated antagonism.  
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Figure 16.  Ethanol differentially modulates the NMDA-R in WT and 
tPA-/- mice.  WT and tPA-/- P7 mice were injected with either ethanol or 
saline, and the forebrain NMDA-R subunit composition analyzed by western 
blot.  WT and tPA-/- have no baseline differences in total NR1 or NR2B (A, 
B, and C; P > 0.05).  However, 24 hours after ethanol administration, NR2B 
was significantly increased above the baseline in the tPA-/- but not WT 
forebrain (D and E; ***, P < 0.0001).  We found NR2A baseline levels were 
higher in the tPA-/- than in the WT (G; *, P < 0.05), and ethanol further 
increased NR2A in tPA-/- 24 hours after ethanol (F and H; *, P < 0.05).  
While ethanol increased NR2A in the tPA-/-, it decreased the subunit 
expression in the WT mice (H; *, P < 0.05).  The effect of ethanol on NR2A 
was contingent on the genotype of the animals (H; ***, P < 0.0001). 
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Figure 16 
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     There are multiple mechanisms of NMDA-R regulation.  The NR2B subunit 
contains an adaptor protein complex (AP-2) binding site in its C-terminal 
domain.  AP-2 is a component of endocytic clathrin coated pits which regulate 
cell surface expression of NR2B (Prybylowski et al, 2005). Binding of AP-2 to 
NR2B is inversely related to the phosphorylation state of Y1472 residue by Src 
kinases (Roche et al, 2001; Yaka et al, 2002). Therefore phosphorylation at this 
residue leads to decreased AP-2 binding and enhanced NR2B surface 
expression.  We explored the association of AP-2 to NR2B by 
immunoprecipitating ß-adaptin, a component of the AP-2 complex, with an 
NR2B antibody.  We studied WT and tPA-/- mice before and after 6hrs and 24 
hrs of ethanol exposure.  We found that the association of ß-adaptin with NR2B 
was unchanged from control levels in the tPA-/- brain at any of the studied 
timepoints after ethanol (Figure 17).  WT mice however showed reduced 
association of ß-adaptin 6 hrs after ethanol (Figure 17).  However, a significant 
enhancement of ß-adaptin association to NR2B was observed 24 hrs after 
ethanol treatment (Figure 17).  These findings suggest that ethanol’s blockade 
of the NMDA-R led to increased receptor internalization, possibly leading to 
impaired synaptogenesis and neurodegeneration in the WT brain.  The 
decreased association of ß-adaptin 6 hrs after ethanol in the WT mice could be 
due to a homeostatic mechanism induced to counterbalance inhibition of NR2B 
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in the presence of ethanol.  However, the reduced association observed at 24 hrs 
is consistent with the decrease in circulating levels of ethanol and concomitant 
with neurodegeneration.  tPA-/- mice, however, did not show any changes in ß-
adaptin association to NR2B after ethanol (Figure 17), suggesting the stability 
of the NMDA receptor complex was not affected by ethanol, and as a result the 
establishment of new synaptic connections and cell survival processes was not 
hindered. 
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Figure 17.  Ethanol modulates ß-adaptin association to NR2B in WT, 
but not tPA-/- mice.  WT and tPA-/- P7 mice were injected with ethanol or 
saline and sacrificed 24 hours after treatment.  Forebrain homogenates were 
immunoprecipitated with an anti-NR2B antibody, and subsequently probed 
for ß-adaptin to investigate whether ethanol affects NR2B subunit 
internalization.  We found ethanol significantly decreases the association of 
ß-adaptin to NR2B 6 hours post administration (B; *, P < 0.05; **, P < 
0.001) but this association was increased above the baseline 24 hours later. 
ß-adaptin association to NR2B in the tPA-/- was unchanged at any time-point 
after ethanol treatment. 
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3.9 tPA-deficient mice were protected form cognitive defects induced by 
early postnatal ethanol treatment   
We evaluated the cognitive ability of adult mice (8-10 weeks of age) that were 
exposed to ethanol or saline at P7.  We found, consistent with previous reports 
(Ieraci and Herrera, 2005), that WT mice that had undergone ethanol treatment 
at P7 had approximately a 20% reduction in contextual fear conditioning 
compared to the saline treatment group (Figure 18).  In contrast, tPA-/- mice that 
received ethanol at the same age did not show impairments when compared to 
their saline-treated counterparts (Figure 18). Interestingly, there is a baseline 
difference between WT and tPA-/- mice, since saline-treated tPA-/- animals 
exhibited slightly decreased freezing (i.e increased locomotor activity) during 
the contextual test when compared to WT saline-treated mice.  But this 
reduction in freezing between WT and tPA-/- saline treated animals did not 
reflect a lack of learning of the paradigm in the tPA-/- mice since contextual 
freezing for these mice was significantly greater than that observed during 
training.  This suggests that exposure of the immature brain to a binge-like dose 
of ethanol has long-term effects on the brain and as a result, on behavior. These 
effects are commensurate to the vulnerability of the immature brain to ethanol-
induced neurodegeneration, and support a role for tPA as a regulator of ethanol-
induced neurodegeneration and FAS development. 
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Figure 18. Neonatal exposure to ethanol induces learning and memory 
deficits in WT, but not tPA-/- mice.  WT and tPA-/- P60-90 that had been 
treated with ethanol or saline at P7 were tested on the fear conditioning 
paradigm.  WT mice that had been treated with ethanol at P7 showed a 
decrease in fear conditioning as observed by a 20% reduction in freezing 
behavior when compared to WT mice that had been exposed to saline (*, P < 
0.05).  Ethanol did not induce differences in the adult tPA-/- mice, since 
ethanol- and saline-treated mice showed similar freezing behavior.   
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3.10 Ethanol treatment increased neuronal-associated tPA activity in 
perinatal PAI-1-/- mouse pups 
     Since PAI-1, the main inhibitor for tPA in the brain, was regulated by 
ethanol in WT mice we decided to investigate what role, if any, PAI-1 plays 
in ethanol-induced neuronal death.   We subjected WT, tPA-/-, and PAI-1-/- 
postnatal age 7 to the acute ethanol binge paradigm that serves as a model 
for FAS in mice.  Mice were injected as described earlier with ethanol at a 
dose of 2.5g/kg at 0 and 2 hrs.  Control mice were injected with equal 
volumes of saline.  We sacrificed mice at different time-points after ethanol 
treatment, and visualized tPA activity in PAI-1-/- forebrain homogenates 
using in-gel zymography.  We found tPA activity was significantly increased 
over 1.5-fold 30 mins and 1 hr (Figure 19A and 19B) after ethanol.  
However, contrary to the long-lasting tPA increase observed in WT mice, 
the increase in activity was reduced back to the baseline in the PAI-1-/- mice 
8 hrs after ethanol, and continued to be decreased at 24 hours (data not 
shown).  
3.11 Ethanol modulates PAI-1 in a tPA-independent manner 
      Since PAI-1 levels were regulated by ethanol in the WT mice, we were 
then interested in examining PAI-1 in the tPA-/- mice using an enzyme-
linked immunosorbent assay (ELISA).  We were surprised to find out that 
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tPA-/- mice have significantly higher baseline levels of PAI-1 than WT 
(Figure 19C).  Contrary to what was observed in the WT brain, ethanol 
treatment did not enhance PAI-1 levels further in the tPA-/-.  However, 24 
hours after ethanol, PAI-1 was downregulated below the baseline for both 
WT and tPA-/- mice, suggesting ethanol-induced modulation of PAI-1 occurs 
independently of tPA. The results also raise the possibility that PAI-1 might 
be involved in the ethanol response in the tPA-/- mice, possibly as a source of 
neuroprotection.   
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 PAI-1 levels 
 
Figure 19. Ethanol treatment increased tPA activity in perinatal PAI-1-/- 
mouse pups, and modulated PAI-1 in a tPA-independent manner.  WT, 
tPA-/-, and PAI-1-/- P7 pups were injected with ethanol or saline as a control. 
In-gel zymography revealed tPA activity is significantly increased in the 
PAI-1-/- mice 0.5hr and 1 hr after ethanol exposure (A and B; **, P < 0.001).  
ELISA of WT and tPA-/- homogenates showed baseline PAI-1 levels are 
significantly higher in the tPA-/- when compared to WT mice (C; **, P < 
0.001).  PAI-1 levels were decreased below the baseline for both WT and 
tPA-/- 24 hrs after ethanol, indicating ethanol-mediated modulation of PAI-1 
occurs independently of tPA. 
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3.12 PAI-1-deficient pups are more vulnerable to ethanol-induced 
neurodegeneration 
     Since baseline levels of PAI-1 were higher in the tPA-/- animals, we 
hypothesized PAI-1-deficient mice might be more vulnerable to ethanol-
induced neurodegeneration.  We found that 24 hours after ethanol 
administration PAI-1-/- mice showed enhanced neuronal death than WT 
mice, as observed by increased FJB staining.  PAI-1-/- showed 
neurodegeneration most prominently in the cerebral cortex (Figure 20A), 
and in the thalamus (Figure 21A).  Neurodegeneration in the cortex of PAI-
1-/- mice was close to 100-fold greater in the cortex (Figure 20G), and over a 
100-fold in the thalamus (Figure 21G) of PAI-1-/- mice when compared to 
WT.  PAI+/- mice showed neurodegeneration similar to WT mice (Figure 
20G and 21G). It was possible that the difference in neurodegeneration in 
PAI-1-/- and WT could have been an artifact of differing blood ethanol 
concentrations, perhaps reflective of underlying metabolic differences 
between the two genotypes, and not to a primary difference in neuronal 
physiology.  To address this possibility, we determined the blood ethanol 
concentrations following treatment.  We found no difference in blood 
ethanol concentrations between PAI-1-/- and WT mice (Figure 22) at any 
timepoint studied.  This result verifies that the observed difference in the 
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severity of neurodegeneration in the PAI-1-/- mice was not due to differences 
in the rate of ethanol metabolism between mouse genotypes.  These data 
show that lack of PAI-1 exacerbates the neurotoxic effects of ethanol, and 
provides support to the hypothesis that PAI-1 promotes neuronal survival 
after ethanol exposure. 
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Figure 20. PAI-1-deficient pups were more vulnerable to ethanol-
induced neurodegeneration in the cortex.  WT, tPA-/-, and PAI-1-/- P7 
pups were injected with ethanol or saline, and sacrificed 24 hrs later to 
determine neuronal death using FJB staining.  PAI-1-/- mice showed 
increased neurodegeneration in the cortex when compared to WT treated 
mice (A and C; *, P < 0.05).   
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Figure 21. PAI-1-deficient pups were more vulnerable to ethanol-
induced neurodegeneration in the thalamus.  WT, tPA-/-, and PAI-1-/- P7 
pups were injected with ethanol or saline, and sacrificed 24 hrs later to 
determine neuronal death using FJB staining.  PAI-1-/- mice showed 
increased neurodegeneration in the cortex when compared to WT treated 
mice (A and C; *, P < 0.05). 
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Figure 22.  Blood ethanol concentrations are similar in WT and PAI-1-/-.  
WT and PAI-1-/- P7 pups were injected with ethanol or saline as a control 
(N=5/group).  Mice were sacrificed at 0hr after treatment, and every 2 hrs 
for the remaining 12 hrs after injection, trunk blood was collected, and 
ethanol concentrations were obtained from plasma.  There were no 
differences in ethanol levels between WT and PAI-1-/-, suggesting the rate of 
metabolism was similar in both genotypes. 
 
3.13 tPA promotes ethanol-induced neurodegeneration in PAI-1-/- mice           
     To determine whether the increased tPA activity seen in the PAI-1-/- brain 
following ethanol treatment was associated with neuronal loss, we injected 
i.p. PAI-1-/- pups with the small molecular weight inhibitor tPA-STOP  
(10ug/g) 30 minutes before ethanol treatment.  We have previously shown 
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this drug can significantly decrease tPA activity both in vitro and in vivo 
(Figure 7I and 7K), and consequently attenuated ethanol-induced 
neurodegeneration in WT mice (Figure 7).  PAI-1-/- mice pretreated with 
tPA-STOP showed a significant attenuation of neurodegeneration after 
ethanol as observed by decreased FJB staining (Figure 23).  The number of 
FJB-positive cells after ethanol was reduced ~100-fold, in both the cortex  
(Figure 23B and 23E) and the thalamus (Figure 23D and E), in comparison 
to PAI-1-/- animals treated only with ethanol (Figure 23A and 23C).  These 
findings indicate that tPA promotes ethanol-induced neurodegeneration in 
the PAI-1-/- brain.  
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Figure 23.  tPA promotes ethanol-induced neurodegeneration in PAI-1-/- 
mice.  PAI-1-deficient P7 pups were administered different treatments: tPA-
STOP (10ug/g) 30 mins prior to acute binge ethanol, tPA-STOP alone, acute 
binge ethanol alone, or saline control.  Pre-treatment with tPA-STOP 
significantly attenuated ethanol-induced neurodegeneration as observed by 
decrease FJB staining in both the cortex (B) and thalamus (D), when 
compared to non-tPA STOP-treated ethanol exposed PAI-1-/- mice (A and C; 
***, P < 0.0001). 
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 3.14 Ethanol decreased nNOS expression in PAI-1-/- mice 
     NO is produced by neuronal nitric oxide synthase (nNOS) after calcium 
induced activation of calmodulin.  Mice deficient in nNOS exhibited 
increased vulnerability to ethanol-induced neurodegeneration, particularly in 
the cingulate cortex and nuclei of the thalamus (Bonthius et al, 2006).  Since 
ethanol increased nNOS expression in the tPA-/- mice suggesting it might be 
part of a survival pathway that protects these mice from ethanol-induced 
neurotoxicity, we evaluated nNOS levels in the PAI-1-/- brain after ethanol 
treatment.  Western blot analysis showed ethanol decreased below baseline 
levels nNOS expression 24 hours after treatment in PAI-1-/- mice (Figure 
24). The ethanol-induced reduction in nNOS in the PAI-1-/- mice was 
significant when compared to WT and tPA-/- treated with ethanol (Figure 
24).  These results are consistent with the pro-survival role that has been 
described for nNOS activity after ethanol exposure of the immature brain, 
and concomitant with our neurodegeneration findings.   
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Figure 24. Ethanol decreased nNOS expression in PAI-1-/- mice.  Since 
ethanol increased nNOS expression in the tPA-/- mice suggesting it might be 
part of a survival pathway that protects these mice from ethanol-induced 
neurotoxicity.  We evaluated nNOS levels in the PAI-1-/- P7 mice after 
ethanol treatment (N=4).  Western blot analysis showed ethanol decreased 
below baseline levels nNOS expression 24 hours after treatment in PAI-1-/- 
mice (A). The ethanol-induced reduction in nNOS in the PAI-1-/- mice was 
significant when compared to WT and tPA-/- treated with ethanol (B; *, P < 
0.05; ***, P < 0.0001). 
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3.15 PAI-1 promotes neuronal survival and tPA promotes neuronal 
death after ethanol treatment 
      To investigate the potential role of PAI-1 in the neuronal protection from 
ethanol-induced toxicity observed in tPA-/- mice, we developed mice that are 
deficient in tPA and heterozygous for PAI-1 (i.e. tPA-/-:PAI-1+/-) by crossing 
double knock-out (tPA-/-:PAI-1+/-) mice with tPA-/-.  Analysis of FJB-
positive staining revealed tPA-/-:PAI+/- mice are more vulnerable to 
neurodegeneration than tPA-deficient mice, but less susceptible than WT 
mice (Figure 25).  Ethanol-induced neurodegeneration, as reflected by FJB 
staining, was observed in the cortical (Figure 25A) and thalamic (Figure 
25B) regions of tPA-/-:PAI+/-. These results suggest PAI-1 promotes neuronal 
survival in tPA-/- mice after ethanol treatment, since lack of a PAI-1 allele, 
which presumably results in reduced protein levels, is sufficient to enhance 
neuronal death in the absence of tPA.  
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Figure 25. PAI-1 promotes neuronal survival and tPA promotes 
neuronal death after ethanol treatment. 
To investigate the potential role of PAI-1 in the neuronal protection from 
ethanol-induced toxicity observed in tPA-/- mice, we developed mice that are 
deficient in tPA and hemizygous in PAI-1 (i.e. tPA-/-:PAI-1+/-). Analysis of 
FJB-positive staining revealed tPA-/-:PAI+/- mice are more vulnerable to 
neurodegeneration than tPA-deficient mice, but less susceptible than WT 
mice.  Ethanol-induced neurodegeneration, as reflected by FJB staining, was 
observed in the cortical (A) and thalamic (B) regions of tPA-/-:PAI+/- (**, P < 
0.001; ***, P < 0.0001). Figure 25 G shows PCR analysis used to determine 
the genotype of the animals used in the experiment. 
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3.16 Chronic stress increases hippocampal tPA activity in WT and PAI-1-
deficient adult mice 
     Chronic restraint stress causes hippocampal-dependent cognitive deficits that 
are consistent with hippocampal structural changes.  Chronic stress results in 
the atrophy of dendritic spines, and decreased expression of NR1 and NR2B 
subunits in the CA1 region that lead to impaired learning of the Morris water 
maze task in WT mice.  tPA-/- mice are protected from these stress-induced 
molecular, structural and behavioral effects (Pawlak  et al, 2005). In addition, 
PAI-1, has also been shown to be modulated by stress (Norris and Strickland, 
2007).  To investigate whether chronic stress leads to increased tPA activity in 
the hippocampus, adult WT and PAI-1-/- mice were restrained 6 hours a day for 
21 days, and sacrificed the following morning after the end of stress.  Increased 
extracellular tPA activity was observed via in situ zymography in the 
hippocampus of WT and PAI-1-/- mice that had been chronically stressed 
(Figure 26).  The area of lysis (indicative of tPA activity) was increased 200% 
in the WT mice that had been chronically stressed over the non-stressed levels 
(Figure 26A and B).  The increase in area of lysis observed in the PAI-1-/- mice 
exceeded 200% (Figure 26C and D), when compared to non-stressed animals of 
the same genotype.   
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Figure 26. Chronic stress increases hippocampal tPA activity in WT 
and PAI-1-/- mice.   To investigate if chronic stress regulates hippocampal 
tPA, adult WT and PAI-1-/- mice were restrained for 21 days and sacrificed 
on day 22 following the end of stress.  The brains were sectioned and 
analyzed for extracellular tPA activity.  Increased tPA activity was observed 
in the mossy fiber pathway of the hippocampal formation of chronically 
restrained WT and PAI-1-/- mice (A and C).  Stress increased the area of 
lysis in the hippocampus from ~20% to ~40% in both genotypes (B and D; 
***, P < 0.0001). 
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3.17 Chronic stress decreases hippocampal PAI-1 levels in WT mice 
     Since chronic stress increased extracellular tPA activity in the hippocampus 
of WT and PAI-1-/- mice, we investigated if PAI-1 is also regulated by chronic 
stress.  Upon completion of 21 days of restraint, stressed and non-stressed WT 
mice were sacrificed and PAI-1 levels in hippocampal homogenates were 
determined using an ELISA.  Chronic stress significantly decreased by 200% 
total PAI-1 antigen when compared to non-stressed WT mice (Figure 27).  
 
 
 
Figure 27. Chronic stress decreased hippocampal PAI-1 levels in WT 
mice.  To further determine if stress modulates the tPA/PAI-1 system, we 
analyzed PAI-1 levels in the hippocampus of chronically restrained WT 
mice with ELISA.  Results indicate PAI-1 levels were significantly 
decreased after chronic stress (*, P < 0.05). 
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3.18 Chronic stress decreases fear conditioning in WT and PAI-1-/- mice, 
but not in tPA-/- 
     To investigate whether the stress-induced changes in tPA activity and PAI-1 
result in changes in learning and memory, we tested WT, tPA-/-, and PAI-1-/- 
adult animals in fear conditioning.  Animals were restraint stressed for 21 days, 
or non-stressed as controls, and upon completion of restrain the mice were 
tested in fear conditioning.  Baseline freezing behavior to the conditioning 
chambers was measured on the first day of the protocol, before starting the 
conditioning to electrical shocks.  There were no differences in baseline 
freezing between genotypes (Figure 28).  When animals were tested for 
contextual conditioning on the second day, chronically stressed WT and PAI-1-/- 
mice showed ~ 20% decrease in freezing when compared to their non-stress 
counterparts, reflective of impaired learning and/or memory probably due to 
chronic stress.  Restraint stressed tPA-/- mice did not show differences in 
freezing behavior when compared to non-stressed tPA-/- controls.  Also, tPA-/- 
mice appear to be naturally more hyperactive than WT and PAI-1-/-. Non-
stressed tPA-/- mice show reduced contextual freezing when compared to non-
stressed WT and PAI-1-/-.     
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Figure 28. Chronic restraint impairs contextual fear conditioning in WT 
and PAI-1-/- mice but not tPA-/-.  Adult WT, PAI-1-/-, and tPA-/- mice that 
had been chronically restrained or non-restrained (control) were tested on 
fear conditioning.  Stressed WT and PAI-1-/- show a significant reduction in 
freezing behavior when compared to the non-stressed animals of the same 
genotype (**, P < 0.001). Stress did not have an effect on the tPA-/- mice.  
Furthermore, there were basal differences in freezing between the non-
stressed WT and PAI-1 when compared to non-stressed tPA-/- (***, P < 
0.0001). 
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CHAPTER 4: DISCUSSION  
4.1 Ethanol and neurotoxicity in a murine model of FAS 
     FAS is a prevalent disease in our society and there is currently no cure, 
other than prevention, for this life-long affliction.  The effects of ethanol on 
the developing brain are particularly important because these often result in 
behavioral and cognitive complications that not only have a serious impact 
on the individual, but also place a burden on society. It is speculated that the 
behavioral sequelae, and specifically the cognitive deficits that are 
associated with FAS originate from brain mass loss and massive forebrain 
neurodegeneration resulting from high doses of ethanol.  Therefore we 
sought to determine whether tPA is a component of the molecular cascade 
leading to neuronal death. 
     The data presented in this study identify tPA as a key molecular regulator 
of the neurotoxic effects of alcohol in a well-accepted murine model of FAS 
(Ikonomidou et al, 2000; Ieraci and Herrera, 2006; Maas et al, 2005; Heck et 
al, 2008).  We found tPA signaling is upstream of the apoptotic cascade and 
of the NMDA-R.  Our results also suggest tPA does not require proteolysis 
or plasmin activation to induce neurodegeneration after ethanol.  Except for 
mice that are deficient in core apoptotic molecules (e.g BAX), no other 
transgenic mouse line has shown resistance to the ethanol-induced 
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neurotoxicity and the subsequent cognitive deficits that are characteristic of 
FAS.   
      Furthermore, our data implicates the major inhibitor for tPA in the brain, 
PAI-1, as an important regulatory component of neuronal survival after 
ethanol.  In our model of FAS, PAI-1-/- mice were more vulnerable to 
neurodegeneration than WT after ethanol treatment.  Our data indicate PAI-1 
can provide trophic support to neurons in the presence of ethanol, tPA-/-: 
PAI-1+/- mice are more susceptible to neurodegeneration after ethanol than 
tPA-deficient animals. 
 
4.2 Ethanol modulates tPA activity and PAI-1 expression in WT pups 
     We found that postnatal day 7 WT mice exposed to acute-binge ethanol 
showed changes in tPA activity and PAI-1 expression. Ethanol treatment 
elevated tPA activity for a period close to 24 hrs. tPA up-regulation was 
accompanied by an increase in PAI-1 levels.  PAI-1 expression, however, 
was increased for less than 6 hrs after ethanol.  Interestingly, PAI-1 was 
downregulated below baseline levels at 24 hours, suggesting ethanol 
modulation of PAI-1 is independent of tPA activity.  It is probable the 
increase in PAI-1 observed after ethanol was not sufficient to counterbalance 
the increase in tPA, and consequently interfere with its activity and/or 
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interactions.  Moreover, PAI-1 modulation after ethanol exposure occurred 
independently of changes in tPA activity, which favored the hypothesis of a 
tPA-independent modulation of PAI-1 after ethanol exposure. 
 
4.3 tPA-/- mice are resistant to ethanol-induced apoptotic signaling and 
neurodegeneration  
     Imaging studies of humans with FAS show a high incidence of 
microencephaly (Swayze et al, 1997), reductions in cortical gray matter and 
total brain volumes (Rivkin et al, 2008), decreased size of the basal ganglia 
(Mattson et al, 2006), and abnormal development or in some cases absence 
of the corpus callosum (Bookstein et al, 2002).  In our experiments, WT 
mice showed over a 100-fold increase in FJB staining in the thalamus and 
cortex when compared to the saline-treated control mice.  In comparison, 
tPA-deficient mice showed less than a 4-fold increase in FJB staining after 
ethanol.  Concomitantly, activation of caspase-3, a key effector molecule in 
the apoptotic cascade, was observed in WT, but not tPA-/-, confirming the 
results observed with FJB.  The effects of tPA appeared to be dependent on 
gene-dosage since hemizogous tPA mice (tPA+/-), which probably exhibit 
reduced production of tPA in the brain, showed intermediate susceptibility to 
neuronal death between what was observed in the WT and tPA-/- animals.  
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Furthermore, since blood ethanol levels were similar in WT and tPA-/- 
animals after treatment, we concluded the effects of tPA on ethanol-induced 
neurodegeneration were not due to underlying differences in the rate of 
metabolism, but on the acute effects of tPA on neuronal physiology.  In 
addition, ethanol treatment resulted in plasma concentrations that were 
consistent with the criteria required to induce neurodegeneration 
(Ikonomidou et al, 2000).  In addition, there were no obvious differences in 
the time of loss of righting reflex after ethanol between WT and tPA-/- mice 
(personal observation), supporting that rate of ethanol metabolism is not the 
underlying mechanism for tPA-mediated ethanol-induced 
neurodegeneration. 
 
4.4 tPA-induced neurodegeneration after ethanol is independent of 
proteolysis and plasmin production  
     Since tPA involvement in excitotoxic neuronal death is contingent on 
plasminogen activation (Tsirka et al, 1995), we investigated ethanol-induced 
neurodegeneration in plasminogen-deficient animals.  We found Plg-/- mice 
were just as vulnerable to ethanol-induced neurotoxicity as WT mice, 
suggesting a plasmin-independent pathway was activated in tPA-mediated 
neuronal death.  Indeed, in the brain tPA can function independently of the 
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typical plasminogen/plasmin proteolysis cascade through the modulation of 
the NMDA-R or stimulation of the LRP receptor (Pawlak et al, 2005; Norris 
and Strickland, 2007; Wang et al, 2003).  It was reported tPA can directly 
cleave the NR1 subunit of the NMDA-R leading to increased calcium influx 
and excitotoxicity  (Nicole et al, 2001).  However, our laboratory has not 
been able yet to replicate this finding.  Our data suggest tPA proteolytic 
activity is not a requirement to promote ethanol-induced neurodegeneration. 
The catalytically inactive S481A tPA, when administered to tPA-deficient 
mice, partially restored ethanol-induced neurodegeneration.  The attenuation 
in neurodegeneration observed after tPA-STOP treatment might arise from 
preclusion of tPA-PAI-1 acyl-enzyme complex formation and downstream 
LRP interactions.  It is also possible that association of tPA-STOP to tPA 
might have altered protease interactions with the NMDA-R or LRP, which 
has been reported to mediate a tPA-induced increase in matrix 
metalloproteinase-9 (MMP-9) resulting in neuronal death (Wang et al, 2003; 
Hu et al, 2006), or with a yet to de described binding partner.   Future 
research will address the nature of tPA’s interactions and signaling partners 
in ethanol-induced neurodegeneration.   
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4.5 tPA-mediated ethanol-induced neurodegeneration occurs via the 
NMDA-R 
    The NMDA-R is critical during development particularly since excitatory 
signaling is crucial for the formation of new synaptic contacts. During brain 
development, up to 25% of the neuronal population is eliminated in early 
postnatal stages during synaptogenesis (for reviews see Hidalgo et al, 2003; 
Benn and Woolf, 2004).  Blockade of the NMDA-R exacerbates the basal 
rate of apoptosis that occurs developmentally, consequently impairing the 
appropriate formation of synapses, and eventually of neuronal circuitry 
(Ikonomidou et al, 1999 and 2000; Ghiani et al, 2007). Our data suggest 
ethanol and, NMDA-R antagonists MK801 and Ro25-691, do not obliterate 
NMDA-R-dependent function in tPA-/- mice.  Interestingly, basal NMDA-R 
function might have been more robust in the tPA-/- mice since increased 
NR2A expression was observed in these mice when compared to WT.  
Consistent with our results, enhanced basal NMDA-R currents in tPA-/- 
slices were observed in adult animals (Park et al, 2008).  It remains unclear 
what the underlying cause is for increased excitatory signaling in these mice.   
     Additionally, NMDA-R function in the tPA-/- mice might have been 
further enhanced as a result of ethanol exposure.  tPA-deficient animals 
showed elevated NR2B, NR2A, BDNF, NGF, and nNOS, 24 hours post 
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ethanol administration. These are proteins that function downstream of the 
NMDA-R and are dependent on calcium signaling.  Ethanol also up-
regulated the expression of the activity-dependent immediate early gene 
cFOS 8 hours post-treatment in the tPA-/-, but not WT mice which suggested 
excitatory signaling was surprisingly improved or enhanced after ethanol.  
Increased NR2A and NR2B might be responsible for downstream increases 
in cFOS, nNOS, and neurotrophic factors.   
     In addition, western blot analysis of crude synaptosomal homogenates 
showed reduced basal PSD-95 protein in the tPA-/- forebrain, consistent with 
a previous study that found reduced association of PSD-95 with the NR2B 
subunit of the NMDA-R (Norris and Strickland, 2007).  These results are 
incredibly fascinating, and support the hypothesis of tPA as a key modulator 
of the receptor, perhaps enabling the appropriate interactions between NR2B 
and PSD-95.  Indeed NR2B -/- mice die within the first week of birth 
(Kutsuwada et al, 1996; Tovar et al, 2000), while PSD-95-/- mice survive 
into adulthood (Kim et al, 2003) suggesting there might be other molecules 
that are essential during early development.  A potential candidate is 
synaptic ras GTPase-activating protein (SynGAP), and just like NR2B-/- 
mice, SynGAP null mutants die early after birth (Komiyama et al, 2002). 
Although SynGAP binds PSD-95 in the adult PSD, both genes have distinct, 
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as well as overlapping expression. The expression of SynGAP in the murine 
brain peaks during synaptogenesis and developmental plasticity in contrast 
to PSD-95, which is expressed throughout the brain from early embryonic 
stages.  Furthermore, SynGAP shows a spatial pattern restricted mostly to 
the forebrain in contrast to PSD-95, which is also found in mid- and 
hindbrain (Porter et al, 2005). These report indicate that synaptic signaling 
complexes are heterogeneous, and individual components show temporal 
and spatial specificity during development, and might account for the 
discrepancies observed between the neonatal WT and tPA-/- forebrain.  
     As discussed in the introductory section, the NR2 subunits undergo a 
developmental shift after birth.  NR2B is the predominant NR2 subunit at 
birth and early post-natal stages.  NR2A expression begins close to post-
natal day 6, and slowly becomes the predominant subunit at the synapse, 
displacing most of NR2B to extrasynaptic sites (Sheng et al, 1994; Liu et al, 
2004).  NR2A-containing receptors promote neuronal survival while NR2B-
containing receptors promote apoptosis in adult neurons. The mechanism for 
NR2A-mediated survival depends on the activation of the Akt pathway, and 
this molecular cascade involves NO (Liu et al, 2007).  Synaptic NMDA-R 
activation leads to the stimulation of the cAMP response element binding 
(CREB) and extracellular signal-regulated kinase (ERK), whereas 
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extrasynaptic NMDA-R stimulation leads to shutoff of the CREB pathway 
(Hardingham et al, 2002).  In cerebellar granule neurons, NO-mediated 
survival after ethanol-induced neurodegeneration required CREB activation 
and NGF, which we found was increased in the “ethanol-resistant” tPA-/- 
brain.  Consistent with our data, neonatal nNOS-deficient mice showed 
increased neurodegeneration after ethanol in the same FAS paradigm we 
used in our studies  (Bonthius et al, 2006).  And ethanol-induced increase in 
nNOS and NGF, which are in the same neuroprotective pathway (Bonthius 
et al, 2003 and 2006), was observed in the tPA-/- mice.  Enhanced NR2A in 
the tPA-/- brain, as opposed to the decreased observed in the WT, might have 
engaged downstream signaling molecules like NO and NGF thus serving as 
a starting advantage against neurotoxicity from ethanol.   
     We also observed increased association of the clathrin-associated ß-
adaptin to the NR2B subunit of ethanol-treated WT 24 hours after treatment.  
We did not observe changes in the tPA-/- mice after ethanol.  Clathrin-
mediated endocytosis serves as a regulatory mechanism for NMDA-R 
surface expression and function (Lavezzari et al, 2004).  Our 
immunoprecipitation results suggest increased clathrin-mediated endocytosis 
of the NMDA-R complex after ethanol exposure.   The observed reduction 
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in NR2A in conjunction to endocytosis of NR2B-containing receptors in the 
WT mice after ethanol might underlie neurodegeneration after treatment.  
 
4.6 tPA-/- mice have increased neurotrophic factor expression 
      A “neurotrophic theory” has been proposed based on data from the 
sympathetic and motor nervous system (Linden 1994; Sendtner, 2000) 
where the select subset of neurons that survive during synaptogenesis do so 
via connection to appropriate targets that supply them with neurotrophic 
factors.  This model of activity-dependent survival comes from in vivo and 
in vitro studies where cortical neurons have shown dependence on the 
activation of the NMDA-R and the consequent synthesis/release of BDNF 
for survival (Lessman et al, 2003; Suzuki et al, 2007).  tPA-/- mice showed 
enhanced expression of BDNF and NGF 24 hrs after ethanol.  It is likely the 
increase in these proteins began at an earlier time-point and provided a 
source of trophic support from ethanol toxicity.  Furthermore, it is likely the 
changes in these proteins in the tPA-/- arise from initial changes observed in 
the NMDA-R subunit composition. 
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4.7 Neonatal ethanol-induced neurodegeneration leads to adult cognitive 
impairments 
     Early exposure to ethanol interferes with the formation of synaptic 
contacts possibly affecting the later development of neural circuits.  The 
cortex, thalamus, and hippocampus, which comprise part of the limbic 
system, are some of the most vulnerable brain regions to ethanol-induced 
neurodegeneration during synaptogenesis.  Consistent with previous reports, 
we show that neonatal exposure of the WT brain, but not tPA-/-, to ethanol 
results in decreased contextual fear conditioning, a learning task that 
depends on intact hippocampal function  (Chen et al, 1996).  Indeed, the 
hippocampus is essential for memory storage, and the thalamus, typically 
referred to as the relay station of the brain, allows communication between 
the cortex and other brain regions, including the hippocampus.  Therefore, it 
was not unexpected that ethanol-induced neurodegeneration was 
commensurate with the behavioral deficits observed in the WT mice.  
 
4.8 tPA is a key regulator of ethanol-induced neurodegeneration and 
FAS development  
     Overall, our data suggests a novel role for the NMDA-R in 
neuroprotection from ethanol’s effects that are opposite from what is 
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observed during excitotoxicity. Increased basal levels of NR2A in the tPA-/- 
brain might be an advantageous starting point through which the NMDA-R 
compensates the blockade of ethanol.  The advantage that increased NR2A 
might provide to the tPA-/- brain is probably enhanced by increased NR2B 
and NR2A at a later timepoint in the presence of ethanol.  These NR2 
subunit differences, and, subsequent changes after ethanol probably boost 
NMDA-R function, nNOS-dependent signaling, and neurotrophic factor 
support.  In fact, nNOS has been shown to protect cultured cerebellar 
neurons from ethanol-induced death via the PKG pathway and NGF 
production.  So it is possible that increased NR2A and NR2B can lead to 
downstream changes such as enhanced nNOS activity, and increased 
neurotrophic signaling that protects cells from the toxic effects of ethanol. 
     It still remains unclear what the trigger for the increased tPA in the WT 
brain might be.  Ethanol depresses synaptic activity through inhibition of the 
NMDA-R and the GABAA-R.  However, tPA is not a constitutively secreted 
protease, it is synthesized and stored in synaptic vesicles in axon terminals, 
and released into the extracellular space upon depolarization (Gualandris et 
al, 1996).  In the adult brain, the answer to ethanol-induced increase in tPA 
might lie in the NMDA-R since chronic exposure stimulates the production 
of more receptors, probably as a compensatory mechanism from ethanol-
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induced inhibition.  As a result, tPA was also increased, and its interaction 
with the NR2B subunit was found necessary for ethanol-induced NMDA-R 
upregulation (Pawlak et al, 2005), thus leading to a positive feedback 
mechanism between the NMDA-R and tPA that was initially stimulated by 
ethanol.  However, this mechanism does not account for what we observed 
in our model with neonatal animals, since we did not observe any evidence 
of ethanol-induced NMDA-R stimulation in the WT brain.  An explanation 
could lie in the cellular source of increased tPA in the brain after acute 
ethanol exposure.  Besides neurons, tPA is also synthesized by microglia 
cells in the brain (Rogove et al, 1999), and these cells can also be activated 
by tPA independently of proteolysis.  As a result, the ethanol-induced 
increase in tPA we observe could be partly due to microglia activation.  This 
is consistent with our findings that suggest tPA induces neurodegeneration 
after ethanol independently of plasminogen and proteolytic activity.  An 
experiment could evaluate neuronal death after the administration of ethanol 
to neonatal mice that are deficient in neuronal- or microglial-specific tPA.  
Furthermore, microglia involvement is likely to only be part of the 
explanation since we observed many basal and ethanol-induced differences 
in NMDA-R subunit composition, NMDA-R-dependent signaling, and PAI-
1 involvement between WT and tPA-/- mice. 
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     Our study shows tPA is a novel molecule crucial in the development of 
FAS.  Exposure of neonatal mice to ethanol leads to widespread 
neurodegeneration, prolonged increase in tPA activity in WT mice, and 
cognitive impairments in adult animals.  tPA-/- mice however do not undergo 
neurodegeneration or develop subsequent cognitive impairment 
characteristic of FAS.  The pharmacological manipulation of tPA levels in 
the brain might be a therapeutic avenue for the treatment of FAS and 
NMDA-R blockade related pathologies.  
 
4.9 Ethanol treatment increased neuronal-associated tPA activity in 
perinatal PAI-1-/- mouse pups 
    PAI-1 serves as the major inhibitor of tPA in the brain and as such is an 
important regulatory component of the tPA/plasmin pathway that is engaged 
in excitotoxicity (Tsirka et al, 1996).  We have shown here that ethanol 
exposure during synaptogenesis differentially modulates tPA activity and 
PAI-1 levels in the forebrain of WT neonatal P7 mice.  Ethanol induced a 
prolonged increase in tPA activity and temporarily upregulated PAI-1 soon 
after treatment.  Levels of PAI-1, however, were downregulated 24 hrs after 
ethanol exposure. Since PAI-1 was regulated by ethanol in WT mice, we 
were interested in evaluating tPA activity in PAI-1-deficient animals.   
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Ethanol treatment increased tPA activity in the forebrain of PAI-1-/- mice, 
but contrary to what is observed in WT, the observed increase in tPA was 
rapid and short-lasting. Though the timeline for increased tPA activity is 
slightly different in WT and PAI-1-/- mice, the increase in tPA in both 
genotypes precede the activation of caspase-3 and consequently 
neurodegeneration, suggesting tPA is an important component of the 
neurodegenerative cascade after ethanol in PAI-1-/- mice.   
 
4.10 Ethanol modulates PAI-1 in a tPA-independent manner 
     PAI-1 modulation by ethanol had been previously observed in cultured 
human endothelial cells where ethanol treatment induced a transcriptional 
decrease of PAI-1 mRNA (Grenett et al, 2000).  In our acute binge paradigm 
that serves as a model for FAS, ethanol initially increased, and progressively 
decreased PAI-1.  The effects observed in PAI-1 after ethanol occur 
independently of tPA, since tPA-/- mice showed a similar pattern of 
modulation after ethanol exposure. Interestingly, we observed PAI-1 
baseline levels were significantly greater in the tPA-/- mice than in WT, and 
since tPA-/- mice are resistant to neurodegeneration, we hypothesized 
elevated levels of PAI-1 might confer neuroprotection from ethanol toxicity 
to these mice.  The feasibility for this proposition is supported by studies 
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that have implicated PAI-1 in neuritogenesis and neuronal survival (Kimura 
et al, 2000; Soeda et al 2001; Guizzeti et al, 2008). 
 
4.11 tPA promotes ethanol-induced neurodegeneration in PAI-1-/- mice  
Indeed, PAI-1-deficient mice showed enhanced vulnerability to 
neurodegeneration after ethanol exposure seen by increased FJB staining in 
the cortical and thalamic regions of the forebrain in comparison to the WT 
mice.  It was possible that the difference in neurodegeneration in PAI-1-/- 
and WT could have been an artifact of differing blood ethanol 
concentrations, perhaps due to underlying metabolic differences between the 
WT and PAI-1-/- mice, and not to a primary difference in neuronal 
physiology.  To address this possibility, we determined the blood ethanol 
concentrations following treatment.  We found no differences in blood 
ethanol concentrations at any time-point studied, suggesting the differences 
observed are not due to the rate of ethanol metabolism. 
     Enhanced neuronal death vulnerability after ethanol exposure was 
partially dependent on increased tPA activity, since treatment with the 
synthetic inhibitor tPA-STOP before EtOH exposure led to attenuation of 
the severity of neurodegeneration in these animals.  This evidence is not 
surprising, since in addition to tPA, PAI-1 interacts with other molecules in 
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the brain (e.g. uPA, vitronectin, and LRP).   Our data suggests that PAI-1 is 
acting independently of tPA, and an interaction of PAI-1 with any of these 
molecules could potentially influence the effects of ethanol, additionally to 
the effects stemming from increased tPA activity.  Furthermore, these results 
suggest that while tPA mediates ethanol-induced neurotoxicity, PAI-1 
mediates a survival-signaling cascade that protects neurons from 
neurodegeneration.  As a result, absence of PAI-1 exacerbates the neurotoxic 
insult by ethanol, supporting the hypothesis that PAI-1 promotes neuronal 
survival after ethanol exposure.   
     What could be the mechanism for PAI-1 in neuronal survival?  PAI-1 is 
secreted by astrocytes and a potential mechanism could entail modifications 
of the extracellular matrix that favor the extension of neurites, thus 
abrogating the effects of ethanol on neuronal activity and consequently 
synaptogenesis.  A recent report showed that PAI-1 upregulation was 
deemed necessary for laminin- and fibronectin-mediated neuritogenesis and 
the extension of neurites during development (Guizzeti et al, 2008).  It is 
unclear though, whether PAI-1 actions are dependent or independent of tPA 
in this study.   
     Another possibility entails PAI-1 in neuronal anti-apoptotic signaling 
(Kimura et al 2000 and Soeda et al 2001).  These studies showed that PAI-1 
 109
deficiency in NGF-differentiated PC12 cells resulted in a significant 
reduction of Bcl-2 and Bcl-XL mRNAs, which typically promote cellular 
survival, and an increase in Bcl-XS and Bax mRNAs, which typically 
promote apoptosis (Soeda et al., 2001).  As a result, changes in the balance 
between mRNAs expressed by the anti- and pro-apoptotic Bcl-2 family 
favored pro-apoptotic signaling, and resulted in cell death.  Ethanol-induced 
neurodegeneration in our model is apoptotic, and requires caspase-3 
activation and cytochrome c release.  It might have been possible that 
elevated levels of PAI-1 in the tPA-/- favored expression of anti-apoptotic 
signaling molecules, thus protecting against ethanol-induced neuronal death 
in these mice.  Thus there are several scenarios through which PAI-1 might 
be exerting neuroprotection, and future studies will address the mechanism 
for PAI-1-mediated neuronal survival after ethanol in neonatal mice. 
 
4.12 Ethanol decreased nNOS expression in PAI-1-/- mice 
      Previous studies have reported that PAI-1 can prevent serum 
deprivation-induced loss of neurites in differentiated PC12 cells (Soeda et 
al., 2004). In the same model system, it was later shown that adding PAI-1, 
in the absence of NGF, can lead to the phosphorylation of Trk A receptors, 
and promote neurite outgrowth and the survival of PC12 cells (Soeda et al, 
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2006).  In the presence of NGF, however, PAI-1 was found to act as a 
synergist since the treatment of NGF-differentiated PC12 cells with anti-Trk 
A receptor antibodies caused neurite disappearance and cell death.  We’ve 
shown tPA-/- mice are resistant to neurodegeneration, and concomitantly, 
these mice show enhanced PAI-1, NGF, BDNF, and nNOS.  WT mice, 
however, have decreased NGF and PAI-1, and lack increased BDNF and 
nNOS.  A feasible mechanism for PAI-1-mediated neuroprotection could 
then be through the synergistic activation of TrkA receptors with NGF.  
      Concomitantly, PAI-1 and NGF could promote neuroprotection from 
ethanol toxicity through nNOS activation.  Particularly since the pro-
survival properties of nNOS after ethanol seem to require NGF (Bonthius et 
al, 2003). nNOS was significantly up-regulated in the tPA-/- mice.  However, 
nNOS expression was unchanged in the WT, and significantly decreased in 
the PAI-1-/- brain.  These results are consistent with the pro-survival role that 
has been described for nNOS activity after ethanol exposure of the immature 
brain, and concomitant with our neurodegeneration findings.  Decreased 
nNOS expression in the PAI-1-/- brain after ethanol exposure, suggest nNOS 
could be part of the neuroprotective pathway engaged by PAI-1 after 
ethanol.    
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4.13 PAI-1 promotes neuronal survival and tPA promotes neuronal 
death after ethanol treatment 
     In order to further dissect the individual contributions tPA and PAI-1 
have in neuronal death and survival after ethanol exposure, we created tPA-/-
:PAI-1+/- mice  by crossing double knock outs with tPA-/- mice.  We found 
that ethanol-induced neurodegeneration in these mice was above what is 
observed in the tPA-/-, but below WT levels.  These mice do not make tPA 
which makes them more resistant to neuronal death, but losing one allele of 
the PAI-1 gene, which likely results in reduced expression of PAI-1 protein, 
is sufficient to significantly increase neuronal death after ethanol.  It is 
possible the elevated levels of PAI-1 in the tPA-/- mice, in conjunction to the 
lack of tPA, serve as an advantage and help protect neurons when exposed to 
ethanol.  Further research into the trophic properties of PAI-1 during 
neonatal brain development might lead open new therapeutic avenues for the 
treatment of FAS-related pathologies. 
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Figure 29.  Model representing ethanol modulation of tPA and PAI-1 in 
the neonatal brain.  Early exposure of the brain to ethanol leads to changes 
in tPA and PAI-1 that result in neurotoxicity.  tPA-deficient animals are 
resistant to ethanol-induced neurotoxicity, implicating tPA as a key regulator 
of the effects of ethanol in the immature brain   We hypothesize that 
abnormal differences in NMDA-R composition and function between WT 
and tPA-/- mice underlies the changes observed in neurodegeneration.  The 
basal composition of the NMDA-R differs between WT and tPA-deficient 
animals, with higher NR2A expression observed in the tPA-/- brain, possibly 
serving as an advantageous starting point that protects against ethanol 
toxicity. NR2A is further increased after ethanol in these mice but decreased 
in the WT mice.  Furthermore, ethanol increased the association of AP-2 to 
NR2B in the WT, suggesting ethanol promoted the internalization of these 
receptors in WT mice.  Ethanol also increased neutrophic factor expression 
in the tPA-/-, suggesting these molecules might serve as a source of 
neuroprotection in the presence of ethanol.  Lastly, PAI-1-/- mice were more 
vulnerable to neurodegeneration, consistent with the observed increased 
basal PAI-1 expression in the tPA-/- brain, suggesting increased PAI-1 in the 
tPA-/- mice might preclude ethanol-induced neurodegeneration in these mice.   
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Figure 29 
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4.14 Ethanol exposure of the immature murine brain can lead to 
learning deficits that are characteristic of FAS in humans 
     Prenatal exposure to ethanol leads to developmental defects in the brain 
that often result in long-lasting behavioral complications, as is the case in 
FAS.  Neonatal P7 rodents that are exposed to binge-like doses of ethanol, as 
we have done in our studies, leads to hyper-activity in the elevated plus 
maze and open field, and impairment of contextual fear conditioning (Ieraci 
and Herrera, 2006).  Our results show that adult WT mice that had been 
treated with ethanol at P7 have decreased contextual, but not cued, fear 
conditioning.  Adult tPA-deficient mice that had been treated with the same 
dose of ethanol did not show differences in fear conditioning when 
compared to saline-treated tPA-/-.  These results are consistent with previous 
reports, and support a causal link between ethanol-induced neuronal death 
with the cognitive impairments that are observed in patients with FAS.  
Furthermore, these results suggest that therapeutic agents that block, or 
attenuate ethanol-induced neurodegeneration, might also be able to prevent 
the cognitive deficits and possibly the development of other behavioral 
disturbances that stem from ethanol exposure. 
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4.15 Chronic stress regulates hippocampal-dependent behavior via 
modulation of the tPA/PAI-1 system 
     tPA has multiple effects in the physiology of the CNS. In particular, tPA 
modulates synaptic plasticity events that underlie several forms of learning 
and memory of spatial memory tasks, LTP, and addiction.  Furthermore, tPA 
is modulated by stress in the hippocampus and amygdala (Pawlak et al, 2003 
and 2005).  The stress-induced increase observed in tPA activity in the 
amygdala is mediated by the stress neuromodulator corticotropin releasing 
factor  (CRF) acting via corticotropin releasing factor receptor type 1 (CRF-
1) (Matys et al, 2004).  tPA-deficient mice exhibit reduced anxiety-like 
behavior to CRF but undergo a sustained corticosterone response after CRF 
administration.  These studies establish tPA as an important mediator of 
cellular, behavioral, and hormonal responses to CRF, and consequently 
stress. 
     We focused on the effects of stress on the hippocampal formation. 
Previous reports from our laboratory showed chronic stress differentially 
affected hippocampal NMDA-R expression, dendritic arborization, and 
Morris water maze learning in WT and tPA-/- mice (Pawlak et al, 2005).  We 
found 21 days of restraint stress significantly elevated extracellular tPA 
activity in WT and PAI-1-/-.   Simultaneously, chronic stress had the opposite 
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effect on PAI-1 levels, reducing it below the baseline in WT mice.  
Furthermore, these changes observed in tPA and PAI-1 were reflected 
behaviorally, as WT and PAI-1-/- animals that had been chronically stressed 
showed decreased contextual, but not cued, fear conditioning.  Chronically 
stressed tPA-/- animals did not undergo changes in either contextual or cued 
fear conditioning.  These data are consistent with the lack of hippocampal 
atrophy observed in the tPA-/- mice.  Furthermore, they implicate PAI-1 as a 
modulator of the stress response in the hippocampus.  It is likely that 
decreased hippocampal levels of PAI-1 in the WT, and the lack of PAI-1 in 
the PAI-1-/- mice, underlie the observed increase in tPA activity.  It might be 
possible the prolonged and elevated levels of tPA due to chronic stress lead 
to detrimental changes in the molecular composition of the extracellular 
matrix that contribute to neuronal atrophy.  Increased tPA might also result 
in degradation of the NMDA-R.  Plasminogen-deficient mice show a 
phenotype similar to that observed in tPA-/- animals (Pawlak et al, 2005), 
suggesting tPA acts via plasmin activation after chronic stress.  Since tPA-
derived plasmin can cleave the NR1 subunit of the NMDA-R (Matys and 
Strickland, 2003) we can speculate this could be an attractive mechanism for 
tPA action after stress.  Increased NR1 cleavage by plasmin could underlie 
the reduction in NMDA-R observed at the end of chronic stress (Pawlak et 
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al, 2005).  Furthermore, cleavage of NR1 could result in increased calcium 
influx and stimulate excitotoxicity and neuronal death.  Overall, these data 
support a role for the tPA/PAI-1 system as key regulators of the cellular and 
behavioral response to chronic stress stimuli.  
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